Publikationer

​Publikationer 2011-2021

1: Siebner TH, Fugl Madelung C, Bendtsen F, Løkkegaard A, Hove JD, Siebner HR.
Postprandial Increase in Mesenteric Blood Flow is Attenuated in Parkinson's
Disease: A Dynamic PC-MRI Study. J Parkinsons Dis. 2021 Jan 5. doi:
10.3233/JPD-202341. Epub ahead of print. PMID: 33427695.

2: Kimer N, Gluud LL, Pedersen JS, Tavenier J, Møller S, Bendtsen F. The
Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis.
Transl Gastroenterol Hepatol. 2021 Jan 5;6:8. doi: 10.21037/tgh.2020.02.14.
PMID: 33409402; PMCID: PMC7724176.

3: Kirkegaard-Klitbo DM, Bendtsen F, Lundgren J, de Knegt RJ, Kofoed KF, Nielsen
SD, Benfield T. Increased prevalence of liver fibrosis in people living with HIV
without viral hepatitis compared to population controls. J Infect Dis. 2020 Dec
15:jiaa763. doi: 10.1093/infdis/jiaa763. Epub ahead of print. PMID: 33320268.

4: Mathiesen DS, Bagger JI, Hansen KB, Junker AE, Plamboeck A, Harring S, Idorn
T, Hornum M, Holst JJ, Jonsson AE, Hansen T, Vilsbøll T, Lund A, Knop FK. No
detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the
incretin effect. Endocr Connect. 2020 Dec;9(12):1221-1232. doi:
10.1530/EC-20-0471. PMID: 33252353; PMCID: PMC7774769.

5: Pedersen JS, Rygg MO, Kristiansen VB, Olsen BH, Serizawa RR, Holst JJ,
Madsbad S, Gluud LL, Bendtsen F, Wewer Albrechtsen NJ. Nonalcoholic Fatty Liver
Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation
and Fibrosis. Hepatol Commun. 2020 Sep 1;4(11):1610-1623. doi:
10.1002/hep4.1562. PMID: 33163832; PMCID: PMC7603528.

6: Kimer N, Riedel AN, Hobolth L, Mortensen C, Madsen LG, Andersen ML, Schiødt
FV, Møller S, Gluud LL. Tunneled Peritoneal Catheter for Refractory Ascites in
Cirrhosis: A Randomized Case-Series. Medicina (Kaunas). 2020 Oct 27;56(11):565. doi: 10.3390/medicina56110565. PMID: 33121063; PMCID: PMC7692861.

7: Vedtofte L, Bahne E, Foghsgaard S, Bagger JI, Andreasen C, Strandberg C,
Gørtz PM, Holst JJ, Grønbæk H, Svare JA, Clausen TD, Mathiesen ER, Damm P, Gluud LL, Knop FK, Vilsbøll T. One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with
Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a
Randomized, Placebo-Controlled Trial. J Clin Med. 2020 Oct 6;9(10):3213. doi:
10.3390/jcm9103213. PMID: 33036179; PMCID: PMC7601647.

8: Kärnsund S, Lo B, Bendtsen F, Holm J, Burisch J. Systematic review of the
prevalence and development of osteoporosis or low bone mineral density and its
risk factors in patients with inflammatory bowel disease. World J Gastroenterol.
2020 Sep 21;26(35):5362-5374. doi: 10.3748/wjg.v26.i35.5362. PMID: 32994694; PMCID: PMC7504246.

9: Winther-Sørensen M, Galsgaard KD, Santos A, Trammell SAJ, Sulek K, Kuhre RE,
Pedersen J, Andersen DB, Hassing AS, Dall M, Treebak JT, Gillum MP, Torekov SS,
Windeløv JA, Hunt JE, Kjeldsen SAS, Jepsen SL, Vasilopoulou CG, Knop FK, Ørskov
C, Werge MP, Bisgaard HC, Eriksen PL, Vilstrup H, Gluud LL, Holst JJ, Wewer
Albrechtsen NJ. Glucagon acutely regulates hepatic amino acid catabolism and the
effect may be disturbed by steatosis. Mol Metab. 2020 Dec;42:101080. doi:
10.1016/j.molmet.2020.101080. Epub 2020 Sep 13. PMID: 32937194; PMCID:
PMC7560169.

10: Kronborg TM, Kimer N, Junker AE, Werge MP, Gluud LL, Ytting H. Experience
from a COVID-19 first-line referral clinic in Greater Copenhagen. Dan Med J.
2020 Aug 7;67(9):A05200343. PMID: 32800070.

11: Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP,
Vesterhus M; European Reference Network on Hepatological Diseases (ERN RARE-
LIVER); International Autoimmune Hepatitis Group (IAIHG). Second-line and third-
line therapy for autoimmune hepatitis: A position statement from the European
Reference Network on Hepatological Diseases and the International Autoimmune
Hepatitis Group. J Hepatol. 2020 Dec;73(6):1496-1506. doi:
10.1016/j.jhep.2020.07.023. Epub 2020 Jul 21. PMID: 32707224.

12: Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, Giovo I,
Uschner FE, Jimenez C, Mookerjee R, Gustot T, Albillos A, Bañares R, Janicko M,
Steib C, Reiberger T, Acevedo J, Gatti P, Bernal W, Zeuzem S, Zipprich A, Piano
S, Berg T, Bruns T, Bendtsen F, Coenraad M, Merli M, Stauber R, Zoller H, Ramos
JP, Solè C, Soriano G, de Gottardi A, Gronbaek H, Saliba F, Trautwein C, Özdogan
OC, Francque S, Ryder S, Nahon P, Romero-Gomez M, Van Vlierberghe H, Francoz C,
Manns M, Garcia E, Tufoni M, Amoros A, Pavesi M, Sanchez C, Curto A, Pitarch C,
Putignano A, Moreno E, Shawcross D, Aguilar F, Clària J, Ponzo P, Jansen C,
Vitalis Z, Zaccherini G, Balogh B, Vargas V, Montagnese S, Alessandria C,
Bernardi M, Ginès P, Jalan R, Moreau R, Angeli P, Arroyo V; PREDICT STUDY group
of the EASL-CLIF Consortium. The PREDICT study uncovers three clinical courses
of acutely decompensated cirrhosis that have distinct pathophysiology. J
Hepatol. 2020 Oct;73(4):842-854. doi: 10.1016/j.jhep.2020.06.013. Epub 2020 Jul 13. PMID: 32673741.

13: Attauabi M, Zhao M, Bendtsen F, Burisch J. Systematic Review with Meta-
analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on
the Disease Course of Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2020 Jul
6:izaa167. doi: 10.1093/ibd/izaa167. Epub ahead of print. PMID: 32628745.

14: Wiese S, Liang M, Mo S, Bendtsen F, Hove JD, Møller S. Left atrial volume
changes assessed by real time 3-dimensional echocardiography in relation to
liver function and prognosis in patients with cirrhosis. Int J Cardiovasc
Imaging. 2020 Nov;36(11):2121-2127. doi: 10.1007/s10554-020-01920-7. Epub 2020 Jul 1. PMID: 32613383.

15: Bollerup S, Hallager S, Baek O, Krarup H, Madsen LG, Thielsen P, Balslev U,
Mens H, Barfod T, Rye Clausen M, Hobolth L, Gerstoft J, Weis N. Implementation
of treatment recommendations for chronic hepatitis B in patients attending
specialized hospital care in Denmark - a region wide study. Scand J
Gastroenterol. 2020 Jul;55(7):843-847. doi: 10.1080/00365521.2020.1779803. Epub 2020 Jun 22. PMID: 32568561.

16: Wiese S, Voiosu A, Hove JD, Danielsen KV, Voiosu T, Grønbaek H, Møller HJ,
Genovese F, Reese-Petersen AL, Mookerjee RP, Clemmesen JO, Gøtze JP, Andersen O, Møller S, Bendtsen F. Fibrogenesis and inflammation contribute to the
pathogenesis of cirrhotic cardiomyopathy. Aliment Pharmacol Ther. 2020
Jul;52(2):340-350. doi: 10.1111/apt.15812. Epub 2020 Jun 11. PMID: 32524673.

17: Rashu EB, Junker AE, Danielsen KV, Dahl E, Hamberg O, Borgwardt L,
Christensen VB, Wewer Albrechtsen NJ, Gluud LL. Cholesteryl ester storage
disease of clinical and genetic characterisation: A case report and review of
literature. World J Clin Cases. 2020 May 6;8(9):1642-1650. doi:
10.12998/wjcc.v8.i9.1642. PMID: 32432142; PMCID: PMC7211528.

18: Kirkegaard-Klitbo DM, Fuchs A, Stender S, Sigvardsen PE, Kühl JT, Kofoed KF,
Køber L, Nordestgaard BG, Bendtsen F, Mocroft A, Lundgren J, Nielsen SD,
Benfield T. Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis
in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver
Study. J Infect Dis. 2020 Sep 14;222(8):1353-1362. doi: 10.1093/infdis/jiaa246.
PMID: 32417886.

19: Petersen AM, Mirsepasi-Lauridsen HC, Vester-Andersen MK, Sørensen N,
Krogfelt KA, Bendtsen F. High Abundance of Proteobacteria in Ileo-Anal Pouch
Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation. Antibiotics (Basel). 2020 May 8;9(5):237. doi:
10.3390/antibiotics9050237. PMID: 32397087; PMCID: PMC7277091.

20: Hadi A, Werge M, Kristiansen KT, Pedersen UG, Karstensen JG, Novovic S,
Gluud LL. Coronavirus Disease-19 (COVID-19) associated with severe acute
pancreatitis: Case report on three family members. Pancreatology. 2020
Jun;20(4):665-667. doi: 10.1016/j.pan.2020.04.021. Epub 2020 May 5. PMID:
32387082; PMCID: PMC7199002.

21: Trebicka J, Gu W, Ibáñez-Samaniego L, Hernández-Gea V, Pitarch C, Garcia E,
Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Silva-Junior G,
Martinez J, Genescà J, Bureau C, Llop E, Laleman W, Palazon JM, Castellote J,
Rodrigues S, Gluud L, Ferreira CN, Barcelo R, Cañete N, Rodríguez M, Ferlitsch
A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo
M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M,
Weiss E, Catalina MV, Erasmus HP, Uschner FE, Schulz M, Brol MJ, Praktiknjo M,
Chang J, Krag A, Nevens F, Calleja JL, Robic MA, Conejo I, Albillos A, Rudler M,
Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Pavesi M, Garcia-Pagán
JC, Jansen C, Bañares R; International Variceal Bleeding Observational Study
Group and Baveno Cooperation. Rebleeding and mortality risk are increased by
ACLF but reduced by pre-emptive TIPS. J Hepatol. 2020 Nov;73(5):1082-1091. doi: 10.1016/j.jhep.2020.04.024. Epub 2020 Apr 24. PMID: 32339602.

22: Bartholdy A, Werge M, Novovic S, Hadi A, Nøjgaard C, Borch A, Feldager E,
Gluud LL, Schmidt PN. Endoscopic treatment with transmural drainage and
necrosectomy for walled-off necrosis provides favourable long-term outcomes on
pancreatic function. United European Gastroenterol J. 2020 Jun;8(5):552-558.
doi: 10.1177/2050640620916029. Epub 2020 Apr 23. PMID: 32326877; PMCID:
PMC7268937.

23: O'Connell MB, Hobolth L, Teisner AS, Andersen ML, Kimer N. [Outpatient
control and rehabilitation in decompensated liver cirrhosis should be an
interdisciplinary approach]. Ugeskr Laeger. 2020 Mar 23;182(13):V08190459.
Danish. PMID: 32285784.

24: Monteiro S, Grandt J, Uschner FE, Kimer N, Madsen JL, Schierwagen R, Klein
S, Welsch C, Schäfer L, Jansen C, Claria J, Alcaraz-Quiles J, Arroyo V, Moreau
R, Fernandez J, Bendtsen F, Mehta G, Gluud LL, Møller S, Praktiknjo M, Trebicka
J. Differential inflammasome activation predisposes to acute-on-chronic liver
failure in human and experimental cirrhosis with and without previous
decompensation. Gut. 2021 Feb;70(2):379-387. doi: 10.1136/gutjnl-2019-320170. Epub 2020 Apr 2. PMID: 32241903.

25: Møller S, Kimer N, Barløse M, Bendtsen F. Pathophysiological-based
treatments of complications of cirrhosis. Scand J Gastroenterol. 2020
Apr;55(4):383-394. doi: 10.1080/00365521.2020.1744709. Epub 2020 Apr 1. PMID: 32233873.

26: Thomsen SB, Allin KH, Burisch J, Jensen CB, Hansen S, Gluud LL, Theede K,
Kiszka-Kanowitz M, Nielsen AM, Jess T. Outcome of concomitant treatment with
thiopurines and allopurinol in patients with inflammatory bowel disease: A
nationwide Danish cohort study. United European Gastroenterol J. 2020
Feb;8(1):68-76. doi: 10.1177/2050640619868387. Epub 2019 Aug 3. PMID: 32213059; PMCID: PMC7006001.

27: Praktiknjo M, Monteiro S, Grandt J, Kimer N, Madsen JL, Werge MP, William P,
Brol MJ, Turco L, Schierwagen R, Chang J, Klein S, Uschner FE, Welsch C, Moreau
R, Schepis F, Bendtsen F, Gluud LL, Møller S, Trebicka J. Cardiodynamic state is
associated with systemic inflammation and fatal acute-on-chronic liver failure.
Liver Int. 2020 Jun;40(6):1457-1466. doi: 10.1111/liv.14433. Epub 2020 Mar 30.
PMID: 32162397.

28: Zhao M, Bendtsen F, Petersen AM, Larsen L, Dige A, Hvas C, Seidelin JB,
Burisch J. Predictors of response and disease course in patients with
inflammatory bowel disease treated with biological therapy-the Danish IBD
Biobank Project: protocol for a multicentre prospective cohort study. BMJ Open.
2020 Feb 25;10(2):e035756. doi: 10.1136/bmjopen-2019-035756. PMID: 32102828; PMCID: PMC7045223.

29: Hedin CRH, Sado G, Ndegwa N, Lytvyak E, Mason A, Montano-Loza A, Gerussi A, Saffioti F, Thorburn D, Nilsson E, Larsson G, Moum BA, van Munster KN, Ponsioen
CY, Levy C, Nogueira NF, Bowlus CL, Gotlieb N, Shibolet O, Lynch KD, Chapman RW,
Rupp C, Vesterhus M, Jørgensen KK, Rorsman F, Schramm C, Sabino J, Vermeire S,
Zago A, Cazzagon N, Marschall HU, Ytting H, Ben Belkacem K, Chazouilleres O,
Almer S; International PSC Study Group, Bergquist A. Effects of Tumor Necrosis
Factor Antagonists in Patients With Primary Sclerosing Cholangitis. Clin
Gastroenterol Hepatol. 2020 Sep;18(10):2295-2304.e2. doi:
10.1016/j.cgh.2020.02.014. Epub 2020 Feb 15. PMID: 32068151.

30: Lo B, Holm JP, Vester-Andersen MK, Bendtsen F, Vind I, Burisch J. Incidence,
Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel
Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up.
J Crohns Colitis. 2020 Jul 30;14(7):904-914. doi: 10.1093/ecco-jcc/jjaa019.
PMID: 32016388.

31: Kimer N, Grønbæk H, Fred RG, Hansen T, Deshmukh AS, Mann M, Bendtsen F.
Atorvastatin for prevention of disease progression and hospitalisation in liver
cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial.
BMJ Open. 2020 Jan 23;10(1):e035284. doi: 10.1136/bmjopen-2019-035284. PMID: 31980514; PMCID: PMC7045122.

32: Israelsen M, Dahl EK, Madsen BS, Wiese S, Bendtsen F, Møller S, Fialla AD,
Jensen BL, Krag A. Dobutamine reverses the cardio-suppressive effects of
terlipressin without improving renal function in cirrhosis and ascites: a
randomized controlled trial. Am J Physiol Gastrointest Liver Physiol. 2020 Feb
1;318(2):G313-G321. doi: 10.1152/ajpgi.00328.2019. Epub 2019 Dec 16. PMID:
31841026.

33: Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P,
Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL,
Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison
S, Sanyal AJ; REGENERATE Study Investigators. Obeticholic acid for the treatment
of non-alcoholic steatohepatitis: interim analysis from a multicentre,
randomised, placebo-controlled phase 3 trial. Lancet. 2019 Dec
14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Erratum in: Lancet. 2020 Aug 1;396(10247):312. PMID: 31813633.

34: Kirkegaard-Klitbo DM, Bendtsen F, Lundgren J, Nielsen SD, Benfield T; COCOMO
study group. Poor Concordance Between Liver Stiffness and Noninvasive Fibrosis
Scores in HIV Infection Without Viral Hepatitis. Clin Gastroenterol Hepatol.
2020 Dec;18(13):3049-3050. doi: 10.1016/j.cgh.2019.10.024. Epub 2019 Oct 21. PMID: 31648031.

35: Milman NT, Schioedt FV, Junker AE, Magnussen K. Diagnosis and Treatment of
Genetic <i>HFE</i>-Hemochromatosis: The Danish Aspect. Gastroenterology Res.
2019 Oct;12(5):221-232. doi: 10.14740/gr1206. Epub 2019 Oct 4. PMID: 31636772; PMCID: PMC6785287.

36: Hartmann J, Werge M, Schmidt PN, Hansen EF, Pedersen UG, Kristiansen KT,
Gluud LL, Novovic S. Modified Marshall Score Predicts Mortality in Patients With
Walled-off Pancreatic Necrosis Treated in an Intensive Care Unit. Pancreas. 2019
Oct;48(9):e68-e70. doi: 10.1097/MPA.0000000000001409. PMID: 31609936.

37: Naver AV, Grandt JJV, Rysgaard S, Schmidt PN, Nøjgaard C, Møller S, Novovic
S, Gluud LL. Energy expenditure and loss of muscle and fat mass in patients with
walled-off pancreatic necrosis: A prospective study. Nutrition. 2020
Jan;69:110574. doi: 10.1016/j.nut.2019.110574. Epub 2019 Aug 27. PMID: 31586481.

38: Vester-Andersen MK, Mirsepasi-Lauridsen HC, Prosberg MV, Mortensen CO,
Träger C, Skovsen K, Thorkilgaard T, Nøjgaard C, Vind I, Krogfelt KA, Sørensen
N, Bendtsen F, Petersen AM. Increased abundance of proteobacteria in aggressive
Crohn's disease seven years after diagnosis. Sci Rep. 2019 Sep 17;9(1):13473.
doi: 10.1038/s41598-019-49833-3. PMID: 31530835; PMCID: PMC6748953.

39: Garnæs E, Mortensen C, Hobolth L, Andersen O, Nehlin J, Møller S. Kinetics
of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.
PLoS One. 2019 Aug 29;14(8):e0220697. doi: 10.1371/journal.pone.0220697. PMID: 31465463; PMCID: PMC6715219.

40: Novovic S, Borch A, Werge M, Karran D, Gluud L, Schmidt PN, Hansen EF,
Nøjgaard C, Jensen AB, Jensen FK, Frøkjær JB, Hansen MB, Jørgensen LN, Drewes
AM, Olesen SS. Characterisation of the fibroinflammatory process involved in
progression from acute to chronic pancreatitis: study protocol for a
multicentre, prospective cohort study. BMJ Open. 2019 Aug 21;9(8):e028999. doi:
10.1136/bmjopen-2019-028999. PMID: 31439604; PMCID: PMC6707691.

41: Christiansen LK, Lo B, Bendtsen F, Vind I, Vester-Andersen MK, Burisch J.
Health-related quality of life in inflammatory bowel disease in a Danish
population-based inception cohort. United European Gastroenterol J. 2019
Aug;7(7):942-954. doi: 10.1177/2050640619852532. Epub 2019 May 17. PMID:
31428419; PMCID: PMC6683643.

42: Chrøis KM, Larsen S, Pedersen JS, Rygg MO, Boilsen AEB, Bendtsen F, Dela F.
Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver
tissue. Basic Clin Pharmacol Toxicol. 2019 Aug 12. doi: 10.1111/bcpt.13304. Epub ahead of print. PMID: 31403256.

43: Neermark S, Rasmussen D, Rysgaard S, Gluud LL, Novovic S, Schmidt PN. The
cost of endoscopic treatment for walled-off pancreatic necrosis. Pancreatology.
2019 Sep;19(6):828-833. doi: 10.1016/j.pan.2019.07.042. Epub 2019 Jul 30. PMID: 31383574.

44: Gluud LL, Jeyaraj R, Morgan MY. Outcomes in Clinical Trials Evaluating
Interventions for the Prevention and Treatment of Hepatic Encephalopathy. J Clin
Exp Hepatol. 2019 May-Jun;9(3):354-361. doi: 10.1016/j.jceh.2019.02.004. Epub
2019 Feb 15. PMID: 31360028; PMCID: PMC6637116.

45: Efe C, Taşçilar K, Henriksson I, Lytvyak E, Alalkim F, Trivedi H, Eren F,
Eliasson J, Beretta-Piccoli BT, Fischer J, Calişkan AR, Chayanupatkul M, Coppo
C, Ytting H, Purnak T, Muratori L, Werner M, Muratori P, Rorsman F, Önnerhag K,
Günşar F, Nilsson E, Heurgué-Berlot A, Güzelbulut F, Demir N, Gönen C, Semela D,
Aladağ M, Kiyici M, Schiano TD, Montano-Loza AJ, Berg T, Ozaslan E, Yoshida EM,
Bonder A, Marschall HU, Wahlin S. Validation of Risk Scoring Systems in
Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis. Am J
Gastroenterol. 2019 Jul;114(7):1101-1108. doi: 10.14309/ajg.0000000000000290. PMID: 31241547.

46: Vadera S, Yong CWK, Gluud LL, Morgan MY. Band ligation versus no
intervention for primary prevention of upper gastrointestinal bleeding in adults
with cirrhosis and oesophageal varices. Cochrane Database Syst Rev. 2019 Jun
20;6(6):CD012673. doi: 10.1002/14651858.CD012673.pub2. PMID: 31220333; PMCID: PMC6586251.

47: Wiese S, Hove JD, Mo S, Mygind ND, Tønnesen J, Petersen CL, Clemmesen JO,
Goetze JP, Bendtsen F, Møller S. Cardiac dysfunction in cirrhosis: a 2-yr
longitudinal follow-up study using advanced cardiac imaging. Am J Physiol
Gastrointest Liver Physiol. 2019 Sep 1;317(3):G253-G263. doi:
10.1152/ajpgi.00402.2018. Epub 2019 Jun 19. PMID: 31216181.

48: Zacharias HD, Zacharias AP, Gluud LL, Morgan MY. Pharmacotherapies that
specifically target ammonia for the prevention and treatment of hepatic
encephalopathy in adults with cirrhosis. Cochrane Database Syst Rev. 2019 Jun
17;6(6):CD012334. doi: 10.1002/14651858.CD012334.pub2. PMID: 31204790; PMCID: PMC6572872.

49: Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH,
Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude
CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU,
Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT,
Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG),
Levy C. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis
and Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020
Jan;18(1):179-187.e6. doi: 10.1016/j.cgh.2019.05.013. Epub 2019 May 14. PMID:
31100458; PMCID: PMC6941216.

50: Lo B, Vind I, Vester-Andersen MK, Bendtsen F, Burisch J. Direct and Indirect
Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish
Population-based Inception Cohort. J Crohns Colitis. 2020 Jan 1;14(1):53-63.
doi: 10.1093/ecco-jcc/jjz096. PMID: 31076743.

51: Chelliah T, Werge M, Merc AI, Bisgaard T, Hansen EF, Hansen EF, Schmidt PN,
Novovic S, Gluud LL. Pulmonary dysfunction due to combination of extra-pulmonary causes and alveolar damage is present from first the day of hospital admission in the early phase of acute pancreatitis. Pancreatology. 2019 Jun;19(4):519-523. doi: 10.1016/j.pan.2019.04.009. Epub 2019 Apr 23. PMID: 31036490.

52: Niu L, Geyer PE, Wewer Albrechtsen NJ, Gluud LL, Santos A, Doll S, Treit PV,
Holst JJ, Knop FK, Vilsbøll T, Junker A, Sachs S, Stemmer K, Müller TD, Tschöp
MH, Hofmann SM, Mann M. Plasma proteome profiling discovers novel proteins
associated with non-alcoholic fatty liver disease. Mol Syst Biol. 2019 Mar
1;15(3):e8793. doi: 10.15252/msb.20188793. PMID: 30824564; PMCID: PMC6396370.

53: Møller S, Danielsen KV, Wiese S, Hove JD, Bendtsen F. An update on cirrhotic
cardiomyopathy. Expert Rev Gastroenterol Hepatol. 2019 May;13(5):497-505. doi:
10.1080/17474124.2019.1587293. Epub 2019 Mar 8. PMID: 30802157.

54: Kirkegaard-Klitbo DM, Danielsen KV, Hanson LG, Gluud LL, Siebner HR,
Bendtsen F, Benfield T. [Magnetic resonance imaging for the diagnosis of non-
alcoholic fatty liver disease]. Ugeskr Laeger. 2019 Feb 25;181(9):V11180792.
Danish. PMID: 30799812.

55: Langholm LL, Manon-Jensen T, Karsdal MA, Bendtsen F, Leeming DJ, Møller S.
Enhanced processing of von Willebrand factor reflects disease severity and
discriminates severe portal hypertension in cirrhosis. Eur J Gastroenterol
Hepatol. 2019 Aug;31(8):1040-1048. doi: 10.1097/MEG.0000000000001380. PMID: 30768435.

56: Lehmann J, Praktiknjo M, Nielsen MJ, Schierwagen R, Meyer C, Thomas D, Violi
F, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka
J. Collagen type IV remodelling gender-specifically predicts mortality in
decompensated cirrhosis. Liver Int. 2019 May;39(5):885-893. doi:
10.1111/liv.14070. Epub 2019 Mar 7. PMID: 30739387; PMCID: PMC6594031.

57: Milman NT, Schiødt FV, Junker AE, Magnussen K, Nathan T, Sandahl TD.
[Genetic HFE-haemochromatosis]. Ugeskr Laeger. 2018 Dec 17;180(51):V09180619. Danish. PMID: 30618363.

58: Zhao M, Lo BZS, Vester-Andersen MK, Vind I, Bendtsen F, Burisch J. A 10-Year
Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish
Population-Based Inception Cohort. Inflamm Bowel Dis. 2019 Jun
18;25(7):1227-1236. doi: 10.1093/ibd/izy374. PMID: 30576474.

59: Aamann L, Dam G, Rinnov AR, Vilstrup H, Gluud LL. Physical exercise for
people with cirrhosis. Cochrane Database Syst Rev. 2018 Dec 21;12(12):CD012678. doi: 10.1002/14651858.CD012678.pub2. PMID: 30575956; PMCID: PMC6517144.

60: Dam G, Aamann L, Vistrup H, Gluud LL. The role of Branched Chain Amino Acids
in the treatment of hepatic Encephalopathy. J Clin Exp Hepatol. 2018
Dec;8(4):448-451. doi: 10.1016/j.jceh.2018.06.004. Epub 2018 Jun 27. PMID:
30568347; PMCID: PMC6286665.

61: Bisgaard T, Kaufmann R, Christoffersen MW, Strandfelt P, Gluud LL. Lower
Risk of Recurrence After Mesh Repair Versus Non-Mesh Sutured Repair in Open
Umbilical Hernia Repair: A Systematic Review and Meta-Analysis of Randomized
Controlled Trials. Scand J Surg. 2019 Sep;108(3):187-193. doi:
10.1177/1457496918812208. Epub 2018 Nov 29. PMID: 30488767.

62: Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY.
Carvedilol versus traditional, non-selective beta-blockers for adults with
cirrhosis and gastroesophageal varices. Cochrane Database Syst Rev. 2018 Oct
29;10(10):CD011510. doi: 10.1002/14651858.CD011510.pub2. PMID: 30372514; PMCID: PMC6517039.

63: Damsgaard J, Larsen FS, Ytting H. Reversal of Acute Liver Failure Due to
Wilson Disease by a Regimen of High-Volume Plasma Exchange and Penicillamine.
Hepatology. 2019 Apr;69(4):1835-1837. doi: 10.1002/hep.30323. Epub 2019 Feb 23. PMID: 30357869.

64: Haraldsson S, Roug S, Nøjgaard C, Novovic S, Gluud LL, Feldager E, Schmidt
PN. Extracorporeal shock wave lithotripsy for pancreatic duct stones: an
observational study. Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1399-1403.
doi: 10.1080/00365521.2018.1508611. Epub 2018 Oct 24. PMID: 30353766.

65: Bjerring PN, Gluud LL, Larsen FS. Cerebral Blood Flow and Metabolism in
Hepatic Encephalopathy-A Meta-Analysis. J Clin Exp Hepatol. 2018
Sep;8(3):286-293. doi: 10.1016/j.jceh.2018.06.002. Epub 2018 Jun 20. PMID:
30302046; PMCID: PMC6175738.

66: Møller S, la Cour Sibbesen E, Madsen JL, Bendtsen F. Indocyanine green
retention test in cirrhosis and portal hypertension: Accuracy and relation to
severity of disease. J Gastroenterol Hepatol. 2019 Jun;34(6):1093-1099. doi:
10.1111/jgh.14470. Epub 2018 Oct 4. PMID: 30221390.

67: Kimer N, Gudmann NS, Pedersen JS, Møller S, Nielsen MJ, Leeming DJ, Karsdal
MA, Møller HJ, Bendtsen F, Grønbæk H. No effect of rifaximin on soluble CD163,
mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial. PLoS One. 2018 Sep 5;13(9):e0203200. doi: 10.1371/journal.pone.0203200. PMID: 30183743; PMCID: PMC6124759.

68: Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D,
Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J,
Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha
Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H,
Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-
Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja
JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E,
Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC; International
Variceal Bleeding Observational Study Group and Baveno Cooperation. Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study. Hepatology. 2019 Jan;69(1):282-293. doi: 10.1002/hep.30182. Epub 2018 Dec 10. PMID: 30014519.

69: Bohn Thomsen S, Kiszka-Kanowitz M, Theede K, Gluud LL, Mertz Nielsen A.
Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α
in patients with Crohn's disease. Eur J Gastroenterol Hepatol. 2018
Oct;30(10):1155-1158. doi: 10.1097/MEG.0000000000001194. PMID: 29975242.

70: Werge M, Novovic S, Roug S, Knudsen JD, Feldager E, Gluud LL, Schmidt PN.
Evaluation of local instillation of antibiotics in infected walled-off
pancreatic necrosis. Pancreatology. 2018 Sep;18(6):642-646. doi:
10.1016/j.pan.2018.06.005. Epub 2018 Jun 20. PMID: 29958817.

71: Allegretti AS, Israelsen M, Krag A, Jovani M, Goldin AH, Schulman AR, Winter
RW, Gluud LL. Terlipressin versus placebo or no intervention for people with
cirrhosis and hepatorenal syndrome. Cochrane Database Syst Rev. 2017 Jun
14;6(6):CD005162. doi: 10.1002/14651858.CD005162.pub4. PMID: 29943803; PMCID: PMC6481608.

72: Rix I, Steen Pedersen J, Storgaard H, Gluud LL. Cardiometabolic effects of
antidiabetic drugs in non-alcoholic fatty liver disease. Clin Physiol Funct
Imaging. 2019 Mar;39(2):122-127. doi: 10.1111/cpf.12526. Epub 2018 May 29. PMID: 29808958.

73: Thorsen A, Borch AM, Novovic S, Schmidt PN, Gluud LL. Endoscopic
Necrosectomy Through Percutaneous Self-Expanding Metal Stents May Be a Promising Additive in Treatment of Necrotizing Pancreatitis. Dig Dis Sci. 2018
Sep;63(9):2456-2465. doi: 10.1007/s10620-018-5131-3. Epub 2018 May 24. PMID: 29796908.

74: Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL, Morgan MY. L-ornithine
L-aspartate for prevention and treatment of hepatic encephalopathy in people
with cirrhosis. Cochrane Database Syst Rev. 2018 May 15;5(5):CD012410. doi:
10.1002/14651858.CD012410.pub2. PMID: 29762873; PMCID: PMC6494563.

75: Wiese S, Hove J, Mo S, Mookerjee RP, Petersen CL, Vester-Andersen MK, Mygind ND, Goetze JP, Kjaer A, Bendtsen F, Møller S. Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome. Liver Int. 2018 Sep;38(9):1614-1623. doi: 10.1111/liv.13870. Epub 2018 May 21. PMID: 29714035.

76: Riedel AN, Kimer N, Jensen AH, Dahl EK, Israelsen M, Aamann L, Gluud LL.
Development and predictive validity of the cirrhosis-associated ascites symptom
scale: A cohort study of 103 patients. World J Gastroenterol. 2018 Apr
21;24(15):1650-1657. doi: 10.3748/wjg.v24.i15.1650. PMID: 29686472; PMCID:
PMC5910548.

77: Kornerup LS, Gluud LL, Vilstrup H, Dam G. Update on the Therapeutic
Management of Hepatic Encephalopathy. Curr Gastroenterol Rep. 2018 Apr
11;20(5):21. doi: 10.1007/s11894-018-0627-8. PMID: 29644492; PMCID: PMC5895665.

78: Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagström H, Purnak T,
Muratori L, Werner M, Muratori P, Klintman D, Schiano TD, Montano-Loza AJ, Berg
T, Larsen FS, Alkhouri N, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S.
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric
Patients with Autoimmune Hepatitis. Dig Dis Sci. 2018 May;63(5):1348-1354. doi:
10.1007/s10620-018-5011-x. Epub 2018 Mar 22. PMID: 29569003.

79: Bossen L, Ytting H, Jepsen P, Hamberg O, Ott P, Grønbæk H. [New name and new treatments for primary biliary cholangitits]. Ugeskr Laeger. 2018 Mar
5;180(10):V07170531. Danish. PMID: 29536837.

80: Danielsen KV, Wiese S, Hove J, Bendtsen F, Møller S. Pronounced Coronary
Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival? Dig
Dis Sci. 2018 May;63(5):1355-1362. doi: 10.1007/s10620-018-5006-7. Epub 2018 Mar 8. PMID: 29516327.

81: Maagensen H, Junker AE, Jørgensen NR, Gluud LL, Knop FK, Vilsbøll T. Bone
Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2
Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose. J Clin
Endocrinol Metab. 2018 May 1;103(5):2042-2049. doi: 10.1210/jc.2018-00176. PMID: 29506157.

82: Lo B, Vester-Andersen MK, Vind I, Prosberg M, Dubinsky M, Siegel CA,
Bendtsen F, Burisch J. Changes in Disease Behaviour and Location in Patients
With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based
Inception Cohort. J Crohns Colitis. 2018 Feb 28;12(3):265-272. doi:
10.1093/ecco-jcc/jjx138. PMID: 29506105.

83: Coenraad MJ, Porcher R, Bendtsen F. Hepatic and cardiac hemodynamics and
systemic inflammation in cirrhosis: It takes three to tango. J Hepatol. 2018
May;68(5):887-889. doi: 10.1016/j.jhep.2018.02.007. Epub 2018 Feb 17. PMID:
29462644.

84: Riedel AN, Kimer N, Hobolth L, Gluud LL. Prognosis of patients with ascites
after PleurX insertion: an observational study. Scand J Gastroenterol. 2018
Mar;53(3):340-344. doi: 10.1080/00365521.2018.1436190. Epub 2018 Feb 7. PMID: 29411667.

85: Praktiknjo M, Lehmann J, Nielsen MJ, Schierwagen R, Uschner FE, Meyer C,
Thomas D, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ,
Trebicka J. Acute decompensation boosts hepatic collagen type III deposition and
deteriorates experimental and human cirrhosis. Hepatol Commun. 2018 Jan
18;2(2):211-222. doi: 10.1002/hep4.1135. PMID: 29404528; PMCID: PMC5796334.

86: Bang UC, Watanabe T, Bendtsen F. The relationship between the use of statins
and mortality, severity, and pancreatic cancer in Danish patients with chronic
pancreatitis. Eur J Gastroenterol Hepatol. 2018 Mar;30(3):346-351. doi:
10.1097/MEG.0000000000001060. PMID: 29309396.

87: Voiosu AM, Wiese S, Voiosu TA, Hove J, Bendtsen F, Møller S. Total bile acid
levels are associated with left atrial volume and cardiac output in patients
with cirrhosis. Eur J Gastroenterol Hepatol. 2018 Apr;30(4):392-397. doi:
10.1097/MEG.0000000000001043. PMID: 29227330.

88: Mo S, Bendtsen F, Wiese SS, Kimer N. Low ascitic fluid total protein levels
is not associated to the development of spontaneous bacterial peritonitis in a
cohort of 274 patients with cirrhosis. Scand J Gastroenterol. 2018
Feb;53(2):200-205. doi: 10.1080/00365521.2017.1411973. Epub 2017 Dec 7. PMID: 29214880.

89: Bang UC, Benfield T, Bendtsen F. Letter: safety and efficacy of using
statins in patients with cirrhosis-authors' reply. Aliment Pharmacol Ther. 2017
Dec;46(11-12):1125-1126. doi: 10.1111/apt.14364. PMID: 29105136.

90: Busk TM, Bendtsen F, Poulsen JH, Clemmesen JO, Larsen FS, Goetze JP, Iversen JS, Jensen MT, Møgelvang R, Pedersen EB, Bech JN, Møller S. Transjugular
intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis. Am J Physiol Gastrointest Liver
Physiol. 2018 Feb 1;314(2):G275-G286. doi: 10.1152/ajpgi.00094.2017. Epub 2017 Oct 26. PMID: 29074483.

91: Bang UC, Benfield T, Bendtsen F. Editorial: the role of statins in the
treatment of alcohol-related cirrhosis - Authors' reply. Aliment Pharmacol Ther.
2017 Nov;46(9):893-894. doi: 10.1111/apt.14281. PMID: 29023883.

92: Lo B, Prosberg MV, Gluud LL, Chan W, Leong RW, van der List E, van der Have
M, Sarter H, Gower-Rousseau C, Peyrin-Biroulet L, Vind I, Burisch J. Systematic
review and meta-analysis: assessment of factors affecting disability in
inflammatory bowel disease and the reliability of the inflammatory bowel disease
disability index. Aliment Pharmacol Ther. 2018 Jan;47(1):6-15. doi:
10.1111/apt.14373. Epub 2017 Oct 9. PMID: 28994131.

93: Glargaard S, Boysen T, Pilely K, Garred P, Ytting H. Prognostic value of
lectin pathway molecules and complement proteins in ascitic fluid and blood in
patients with liver cirrhosis. Scand J Gastroenterol. 2018 Jan;53(1):64-69. doi:
10.1080/00365521.2017.1386710. Epub 2017 Oct 6. PMID: 28982257.

94: Wewer Albrechtsen NJ, Junker AE, Christensen M, Hædersdal S, Wibrand F, Lund AM, Galsgaard KD, Holst JJ, Knop FK, Vilsbøll T. Hyperglucagonemia correlates
with plasma levels of non-branched-chain amino acids in patients with liver
disease independent of type 2 diabetes. Am J Physiol Gastrointest Liver Physiol.
2018 Jan 1;314(1):G91-G96. doi: 10.1152/ajpgi.00216.2017. Epub 2017 Sep 28.
PMID: 28971838.

95: Israelsen M, Krag A, Allegretti AS, Jovani M, Goldin AH, Winter RW, Gluud
LL. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
Cochrane Database Syst Rev. 2017 Sep 27;9(9):CD011532. doi:
10.1002/14651858.CD011532.pub2. PMID: 28953318; PMCID: PMC6483765.

96: Vadstrup K, Bendtsen F. Anti-NKG2D mAb: A New Treatment for Crohn's Disease?
Int J Mol Sci. 2017 Sep 16;18(9):1997. doi: 10.3390/ijms18091997. PMID:
28926962; PMCID: PMC5618646.

97: Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and
hyperdynamic circulation in cirrhosis. Liver Int. 2018 Apr;38(4):570-580. doi:
10.1111/liv.13589. Epub 2018 Jan 15. PMID: 28921803.

98: Bang UC, Benfield T, Bendtsen F. Reduced risk of decompensation and death
associated with use of statins in patients with alcoholic cirrhosis. A
nationwide case-cohort study. Aliment Pharmacol Ther. 2017 Oct;46(7):673-680.
doi: 10.1111/apt.14243. PMID: 28880449.

99: Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess
T. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish
population-based cohort study 1977-2011. Liver Int. 2018 Mar;38(3):532-541. doi: 10.1111/liv.13548. Epub 2017 Sep 5. PMID: 28796371.

100: Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no
intervention for people with cirrhosis and hepatic encephalopathy. Cochrane
Database Syst Rev. 2017 Aug 10;8(8):CD002798. doi:
10.1002/14651858.CD002798.pub4. PMID: 28796283; PMCID: PMC6483298.

101: Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no
intervention for people with cirrhosis and hepatic encephalopathy. Cochrane
Database Syst Rev. 2017 Jul 26;7(7):CD002798. doi:
10.1002/14651858.CD002798.pub3. Update in: Cochrane Database Syst Rev. 2017 Aug 10;8:CD002798. PMID: 28745801; PMCID: PMC6483159.

102: Busk TM, Bendtsen F, Henriksen JH, Fuglsang S, Clemmesen JO, Larsen FS,
Møller S. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on
blood volume distribution in patients with cirrhosis. Dig Liver Dis. 2017
Dec;49(12):1353-1359. doi: 10.1016/j.dld.2017.06.011. Epub 2017 Jun 27. PMID: 28729141.

103: Pedersen JS, Kimer N, Henriksen JH, Bendtsen F, Møller S. The royal free
hospital cirrhosis glomerular filtration rate: Validation in a danish cohort.
Hepatology. 2017 Oct;66(4):1360-1361. doi: 10.1002/hep.29386. Epub 2017 Aug 26. PMID: 28727168.

104: Vadstrup K, Galsgaard ED, Jensen H, Lanier LL, Ryan JC, Chen SY, Nolan GP,
Vester-Andersen MK, Pedersen JS, Gerwien J, Jensen T, Bendtsen F. NKG2D ligand
expression in Crohn's disease and NKG2D-dependent stimulation of CD8<sup>+</sup> T cell migration. Exp Mol Pathol. 2017 Aug;103(1):56-70. doi:
10.1016/j.yexmp.2017.06.010. Epub 2017 Jul 3. PMID: 28684217; PMCID: PMC5560431.

105: Kimer N, Pedersen JS, Tavenier J, Christensen JE, Busk TM, Hobolth L, Krag
A, Al-Soud WA, Mortensen MS, Sørensen SJ, Møller S, Bendtsen F; members of the
CoRif study group. Rifaximin has minor effects on bacterial composition,
inflammation, and bacterial translocation in cirrhosis: A randomized trial. J
Gastroenterol Hepatol. 2018 Jan;33(1):307-314. doi: 10.1111/jgh.13852. PMID:
28671712.

106: Efe C, Hagström H, Ytting H, Bhanji RA, Müller NF, Wang Q, Purnak T,
Muratori L, Werner M, Marschall HU, Muratori P, Gunşar F, Klintman D, Parés A,
Heurgué-Berlot A, Schiano TD, Cengiz M, May-Sien Tana M, Ma X, Montano-Loza AJ,
Berg T, Verma S, Larsen FS, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S.
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line
Therapy for Patients With Autoimmune Hepatitis. Clin Gastroenterol Hepatol. 2017
Dec;15(12):1950-1956.e1. doi: 10.1016/j.cgh.2017.06.001. Epub 2017 Jun 8. PMID: 28603052.

107: Junker AE. The role of incretin hormones and glucagon in patients with
liver disease. Dan Med J. 2017 May;64(5):B5363. PMID: 28552096.

108: Markwardt D, Holdt L, Steib C, Benesic A, Bendtsen F, Bernardi M, Moreau R,
Teupser D, Wendon J, Nevens F, Trebicka J, Garcia E, Pavesi M, Arroyo V, Gerbes
AL. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic
liver failure, and mortality in patients with acutely decompensated liver
cirrhosis. Hepatology. 2017 Oct;66(4):1232-1241. doi: 10.1002/hep.29290. Epub
2017 Aug 26. PMID: 28545169.

109: Rysgaard S, Rasmussen D, Novovic S, Schmidt PN, Gluud LL. Effect of
overweight and obesity on weight loss and length of stay in patients with
walled-off pancreatic necrosis. Nutrition. 2017 Jun;38:109-112. doi:
10.1016/j.nut.2017.01.006. Epub 2017 Feb 3. PMID: 28526375.

110: Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, Vilstrup H.
Branched-chain amino acids for people with hepatic encephalopathy. Cochrane
Database Syst Rev. 2017 May 18;5(5):CD001939. doi:
10.1002/14651858.CD001939.pub4. PMID: 28518283; PMCID: PMC6481897.

111: Burisch J, Ungaro R, Vind I, Prosberg MV, Bendtsen F, Colombel JF, Vester-
Andersen MK. Proximal Disease Extension in Patients With Limited Ulcerative
Colitis: A Danish Population-based Inception Cohort. J Crohns Colitis. 2017 Oct
1;11(10):1200-1204. doi: 10.1093/ecco-jcc/jjx066. PMID: 28486626; PMCID:
PMC6279091.

112: Buzzetti E, Kalafateli M, Thorburn D, Davidson BR, Thiele M, Gluud LL, Del
Giovane C, Askgaard G, Krag A, Tsochatzis E, Gurusamy KS. Pharmacological
interventions for alcoholic liver disease (alcohol-related liver disease): an
attempted network meta-analysis. Cochrane Database Syst Rev. 2017 Mar
31;3(3):CD011646. doi: 10.1002/14651858.CD011646.pub2. Epub ahead of print. PMID: 28368093; PMCID: PMC6464309.

113: Trebicka J, Gluud LL. Reply to: "Adding embolization to TIPS implantation:
A better therapy to control bleeding from ectopic varices?". J Hepatol. 2017
Jul;67(1):202-203. doi: 10.1016/j.jhep.2017.03.018. Epub 2017 Mar 24. PMID:
28347803.

114: Hansen M, Sonne DP, Mikkelsen KH, Gluud LL, Vilsbøll T, Knop FK. Bile acid
sequestrants for glycemic control in patients with type 2 diabetes: A systematic
review with meta-analysis of randomized controlled trials. J Diabetes
Complications. 2017 May;31(5):918-927. doi: 10.1016/j.jdiacomp.2017.01.011. Epub 2017 Jan 24. PMID: 28238556.

115: Voiosu A, Wiese S, Voiosu T, Bendtsen F, Møller S. Bile acids and
cardiovascular function in cirrhosis. Liver Int. 2017 Oct;37(10):1420-1430. doi:
10.1111/liv.13394. Epub 2017 Mar 13. PMID: 28222247.

116: Storgaard H, Cold F, Gluud LL, Vilsbøll T, Knop FK. Glucagon-like peptide-1
receptor agonists and risk of acute pancreatitis in patients with type 2
diabetes. Diabetes Obes Metab. 2017 Jun;19(6):906-908. doi: 10.1111/dom.12885. Epub 2017 Mar 17. PMID: 28105738.

117: Busk TM, Møller S, Pedersen EB, Gerbes A, Krag A, Peck-Radosavljevic M,
Frankova S, Coenraad MJ, Bendtsen F. Aquaporin-2 excretion in hospitalized
patients with cirrhosis: Relation to development of renal insufficiency and
mortality. J Gastroenterol Hepatol. 2017 May;32(5):1087-1093. doi:
10.1111/jgh.13641. PMID: 28092112.

118: Baekdal M, Ytting H, Skalshøi Kjær M. Drug-induced liver injury: a cohort
study on patients referred to the Danish transplant center over a five year
period. Scand J Gastroenterol. 2017 Apr;52(4):450-454. doi:
10.1080/00365521.2016.1267790. Epub 2016 Dec 15. PMID: 27973926.

119: de Vries EM, de Krijger M, Färkkilä M, Arola J, Schirmacher P, Gotthardt D,
Goeppert B, Trivedi PJ, Hirschfield GM, Ytting H, Vainer B, Buuren HR, Biermann
K, Harms MH, Chazouilleres O, Wendum D, Kemgang AD, Chapman RW, Wang LM,
Williamson KD, Gouw AS, Paradis V, Sempoux C, Beuers U, Hübscher SG, Verheij J,
Ponsioen CY. Validation of the prognostic value of histologic scoring systems in
primary sclerosing cholangitis: An international cohort study. Hepatology. 2017
Mar;65(3):907-919. doi: 10.1002/hep.28963. Epub 2017 Jan 11. PMID: 27880989.

120: Storgaard H, Gluud LL, Bennett C, Grøndahl MF, Christensen MB, Knop FK,
Vilsbøll T. Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in
Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLoS One.
2016 Nov 11;11(11):e0166125. doi: 10.1371/journal.pone.0166125. PMID: 27835680; PMCID: PMC5106000.

121: Foghsgaard S, Andreasen C, Vedtofte L, Andersen ES, Bahne E, Strandberg C,
Buhl T, Holst JJ, Svare JA, Clausen TD, Mathiesen ER, Damm P, Gluud LL, Knop FK,
Vilsbøll T. Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior
Gestational Diabetes Mellitus and Independently Associated With Insulin
Resistance and Waist Circumference. Diabetes Care. 2017 Jan;40(1):109-116. doi:
10.2337/dc16-1017. Epub 2016 Nov 3. PMID: 27810989.

122: Kimer N, Pedersen JS, Busk TM, Gluud LL, Hobolth L, Krag A, Møller S,
Bendtsen F; Copenhagen Rifaximin (CoRif) Study Group. Rifaximin has no effect on
hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-
controlled trial. Hepatology. 2017 Feb;65(2):592-603. doi: 10.1002/hep.28898.
Epub 2016 Dec 24. PMID: 27775818.

123: Laursen TL, Rødgaard-Hansen S, Møller HJ, Mortensen C, Karlsen S, Nielsen
DT, Frevert S, Clemmesen JO, Møller S, Jensen JS, Bendtsen F, Grønbaek H. The
soluble mannose receptor is released from the liver in cirrhotic patients, but
is not associated with bacterial translocation. Liver Int. 2017
Apr;37(4):569-575. doi: 10.1111/liv.13262. Epub 2016 Oct 21. PMID: 27706896.

124: Bendtsen F. Gammel vin på nye flasker: Laktulose virker ved hepatisk
encefalopati [Old wine in new bottles: Lactulose works in hepatic
encephalopathy]. Ugeskr Laeger. 2016 Oct 17;178(42):V68568. Danish. PMID:
27745574.

125: Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL. The association
between the gut microbiota and the inflammatory bowel disease activity: a
systematic review and meta-analysis. Scand J Gastroenterol. 2016
Dec;51(12):1407-1415. doi: 10.1080/00365521.2016.1216587. Epub 2016 Aug 9. PMID: 27687331.

126: Agra RM, Al-Daghri NM, Badimon L, Bodi V, Carbone F, Chen M, Cubedo J,
Dullaart RP, Eiras S, García-Monzón C, Gary T, Gnoni A, González-Rodríguez Á,
Gremmel T, Hafner F, Hakala T, Huang B, Ickmans K, Irace C, Kholová I, Kimer N,
Kytö V, März W, Miazgowski T, Møller S, Montecucco F, Niccoli G, Nijs J, Ozben
S, Ozben T, Papassotiriou I, Papastamataki M, Reina-Couto M, Rios-Navarro C,
Ritsch A, Sabico S, Seetho IW, Severino A, Sipilä J, Sousa T, Taszarek A,
Taurino F, Tietge UJ, Tripolino C, Verloop W, Voskuil M, Wilding JP. Research
update for articles published in EJCI in 2014. Eur J Clin Invest. 2016
Oct;46(10):880-94. doi: 10.1111/eci.12671. PMID: 27571922.

127: Gluud LL, Miliam PB. Skal vi bruge tranexamsyre til øvre gastrointestinal
blødning? [Should we use tranexamic acid in upper gastrointestinal bleeding?].
Ugeskr Laeger. 2016 Aug 22;178(34):V68420. Danish. PMID: 27549003.

128: Werge M, Novovic S, Schmidt PN, Gluud LL. Infection increases mortality in
necrotizing pancreatitis: A systematic review and meta-analysis. Pancreatology.
2016 Sep-Oct;16(5):698-707. doi: 10.1016/j.pan.2016.07.004. Epub 2016 Jul 9.
PMID: 27449605.

129: Hurry PK, Poulsen JH, Bendtsen F, Møller S. Neutrophil gelatinase-
associated lipocalin and cystatin C in cirrhosis and portal hypertension:
Relations to organ extraction and dysfunction. J Gastroenterol Hepatol. 2017
Feb;32(2):473-481. doi: 10.1111/jgh.13492. PMID: 27435243.

130: Dombernowsky T, Kristensen MØ, Rysgaard S, Gluud LL, Novovic S. Risk
factors for and impact of respiratory failure on mortality in the early phase of
acute pancreatitis. Pancreatology. 2016 Sep-Oct;16(5):756-60. doi:
10.1016/j.pan.2016.06.664. Epub 2016 Jul 8. PMID: 27424478.

131: Rinnov AR, Plomgaard P, Pedersen BK, Gluud LL. Impaired Follistatin
Secretion in Cirrhosis. J Clin Endocrinol Metab. 2016 Sep;101(9):3395-400. doi:
10.1210/jc.2016-1923. Epub 2016 Jul 11. PMID: 27399349.

132: Semb S, Neermark S, Dam-Larsen S, Franzmann MB, Albrectsen J, Kallemose T, Becker U, Bendtsen F. Presence of alcoholic steatohepatitis, but no selective
histological feature, indicates an increased risk of cirrhosis and premature
death. Scand J Gastroenterol. 2016 Nov;51(11):1367-74. doi:
10.1080/00365521.2016.1203016. Epub 2016 Jul 5. PMID: 27381376.

133: Busk TM, Bendtsen F, Møller S. Hepatorenal syndrome in cirrhosis:
diagnostic, pathophysiological, and therapeutic aspects. Expert Rev
Gastroenterol Hepatol. 2016 Oct;10(10):1153-1161. doi:
10.1080/17474124.2016.1196132. Epub 2016 Jun 16. PMID: 27248461.

134: Teisen E, Vainer B, Ytting H. [Hepatitis after chewing of khat leaves].
Ugeskr Laeger. 2016 May 16;178(20):V02160124. Danish. PMID: 27189105.

135: Pind ML, Bendtsen F, Kallemose T, Møller S. Indocyanine green retention
test (ICG-r15) as a noninvasive predictor of portal hypertension in patients
with different severity of cirrhosis. Eur J Gastroenterol Hepatol. 2016
Aug;28(8):948-54. doi: 10.1097/MEG.0000000000000611. PMID: 27172450.

136: Vadstrup K, Galsgaard ED, Gerwien J, Vester-Andersen MK, Pedersen JS,
Rasmussen J, Neermark S, Kiszka-Kanowitz M, Jensen T, Bendtsen F. Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's
Disease: Reflects Inflammation and Drug Effects. PLoS One. 2016 May
12;11(5):e0155335. doi: 10.1371/journal.pone.0155335. PMID: 27171179; PMCID: PMC4865152.

137: Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus
placebo/no intervention and lactulose versus lactitol for the prevention and
treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database
Syst Rev. 2016 May 6;2016(5):CD003044. doi: 10.1002/14651858.CD003044.pub4. PMID: 27153247; PMCID: PMC7004252.

138: Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus
placebo/no intervention and lactulose versus lactitol for the prevention and
treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database
Syst Rev. 2016 Apr 18;4:CD003044. doi: 10.1002/14651858.CD003044.pub3. Update in: Cochrane Database Syst Rev. 2016;(5):CD003044. PMID: 27089005.

139: Gluud LL, Vilstrup H, Morgan MY. Nonabsorbable disaccharides for hepatic
encephalopathy: A systematic review and meta-analysis. Hepatology. 2016
Sep;64(3):908-22. doi: 10.1002/hep.28598. Epub 2016 May 20. PMID: 27081787.

140: Sandahl TD, McGrail R, Møller HJ, Reverter E, Møller S, Turon F, Hernández-
Gea V, Bendtsen F, Vilstrup H, Garcia-Pagan JC, Grønbaek H. The macrophage
activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis
(ELF) score predicts clinically significant portal hypertension in patients with
cirrhosis. Aliment Pharmacol Ther. 2016 Jun;43(11):1222-31. doi:
10.1111/apt.13618. Epub 2016 Apr 7. PMID: 27061098.

141: Bang UC, Benfield T, Hyldstrup L, Jensen JE, Bendtsen F. Effect of
propranolol on survival in patients with decompensated cirrhosis: a nationwide
study based Danish patient registers. Liver Int. 2016 Sep;36(9):1304-12. doi:
10.1111/liv.13119. Epub 2016 Apr 4. PMID: 26992041.

142: Kimer N, Wiese S, Mo S, Møller S, Bendtsen F. Advances in the treatment of
portal hypertension in cirrhosis. Expert Rev Gastroenterol Hepatol. 2016
Aug;10(8):961-9. doi: 10.1586/17474124.2016.1166952. Epub 2016 Mar 28. PMID: 26982499.

143: Trebicka J, von Heydebrand M, Lehmann J, Tofteng F, Busk T, Jensen HL,
Rohde J, Reiberger T, Mortensen C, Schierwagen R, Klein S, Møller S, Bendtsen F,
Krag A. Assessment of response to beta-blockers by expression of βArr2 and
RhoA/ROCK2 in antrum mucosa in cirrhotic patients. J Hepatol. 2016
Jun;64(6):1265-73. doi: 10.1016/j.jhep.2016.01.022. Epub 2016 Jan 28. PMID:
26827791.

144: Prosberg MV, Vester-Andersen MK, Andersson M, Jess T, Andersen JT, Vind I,
Bendtsen F. Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and
Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-
based Cohort Study. Inflamm Bowel Dis. 2016 Apr;22(4):925-32. doi:
10.1097/MIB.0000000000000700. PMID: 26818426.

145: Svane MS, Bojsen-Møller KN, Nielsen S, Jørgensen NB, Dirksen C, Bendtsen F,
Kristiansen VB, Hartmann B, Holst JJ, Madsbad S. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery. Am J Physiol
Endocrinol Metab. 2016 Apr 1;310(7):E505-14. doi: 10.1152/ajpendo.00471.2015. Epub 2016 Jan 19. PMID: 26786780.

146: Wiese S, Timm A, Nielsen LB, Goetze JP, Bendtsen F, Møller S. Plasma
ADAMTS-13 protein is not associated with portal hypertension or hemodynamic
changes in patients with cirrhosis. Dig Liver Dis. 2016 Apr;48(4):404-8. doi:
10.1016/j.dld.2015.12.003. Epub 2015 Dec 17. PMID: 26775093.

147: Fuglsang S, Henriksen UL, Hansen HB, Bendtsen F, Henriksen JH. Gamma-
variate plasma clearance versus urinary plasma clearance of <sup>51</sup> Cr-
EDTA in patients with cirrhosis with and without fluid retention. Clin Physiol
Funct Imaging. 2017 Nov;37(6):588-595. doi: 10.1111/cpf.12336. Epub 2016 Jan 14. PMID: 26769593.

148: Junker AE, Gluud L, Holst JJ, Knop FK, Vilsbøll T. Diabetic and nondiabetic
patients with nonalcoholic fatty liver disease have an impaired incretin effect
and fasting hyperglucagonaemia. J Intern Med. 2016 May;279(5):485-93. doi:
10.1111/joim.12462. Epub 2016 Jan 5. PMID: 26728692.

149: Junker AE, Gluud LL, van Hall G, Holst JJ, Knop FK, Vilsbøll T. Effects of
glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic
fatty liver disease. J Hepatol. 2016 Apr;64(4):908-15. doi:
10.1016/j.jhep.2015.11.014. Epub 2015 Nov 25. PMID: 26626496.

150: Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK. Effect of the
EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic
review and meta-analysis. Diabetes Obes Metab. 2016 Mar;18(3):300-5. doi:
10.1111/dom.12603. Epub 2016 Jan 15. PMID: 26537317.

151: Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, Macnaughtan J, Bendtsen F,
Coenraad M, Sperl J, Gines P, Moreau R, Arroyo V, Jalan R; CANONIC Study
Investigators of the EASL-CLIF Consortium. Treatment with non-selective beta
blockers is associated with reduced severity of systemic inflammation and
improved survival of patients with acute-on-chronic liver failure. J Hepatol.
2016 Mar;64(3):574-82. doi: 10.1016/j.jhep.2015.10.018. Epub 2015 Oct 28. PMID: 26519600.

152: Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK,
Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy.
Cochrane Database Syst Rev. 2015 Sep 17;(9):CD001939. doi:
10.1002/14651858.CD001939.pub3. Update in: Cochrane Database Syst Rev. 2017 May 18;5:CD001939. PMID: 26377410.

153: Vester-Andersen MK, Prosberg MV, Vind I, Andersson M, Jess T, Bendtsen F.
Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with
Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception
Cohort. Inflamm Bowel Dis. 2015 Oct;21(10):2296-303. doi:
10.1097/MIB.0000000000000493. PMID: 26164663.

154: Nielsen MJ, Lehmann J, Leeming DJ, Schierwagen R, Klein S, Jansen C,
Strassburg CP, Bendtsen F, Møller S, Sauerbruch T, Karsdal MA, Krag A, Trebicka
J. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and
Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS. Dig Dis Sci.
2015 Nov;60(11):3456-64. doi: 10.1007/s10620-015-3783-9. Epub 2015 Jul 3. PMID: 26138655.

155: Møller S, Bendtsen F. NAFLD: Cardiovascular complications of NAFLD--they do matter. Nat Rev Gastroenterol Hepatol. 2015 Aug;12(8):434-6. doi:
10.1038/nrgastro.2015.110. Epub 2015 Jun 30. PMID: 26122476.

156: Møller S, Bendtsen F. Cirrhotic Multiorgan Syndrome. Dig Dis Sci. 2015
Nov;60(11):3209-25. doi: 10.1007/s10620-015-3752-3. Epub 2015 Jun 26. PMID: 26112989.

157: Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant
supplements for prevention of mortality in healthy participants and patients
with various diseases. Sao Paulo Med J. 2015 Mar-Apr;133(2):164-5. doi:
10.1590/1516-3180.20151332T1. Epub 2015 Apr 1. PMID: 26018887.

158: Henriksen UL, Kiszka-Kanowitz M, Bendtsen F, Henriksen JH. Red blood cell
sodium transport in patients with cirrhosis. Clin Physiol Funct Imaging. 2016
Sep;36(5):359-67. doi: 10.1111/cpf.12238. Epub 2015 May 27. PMID: 26016736.

159: Henriksen JH, Bendtsen F, Møller S. Acid-base disturbance in patients with
cirrhosis: relation to hemodynamic dysfunction. Eur J Gastroenterol Hepatol.
2015 Aug;27(8):920-7. doi: 10.1097/MEG.0000000000000382. PMID: 26011230.

160: Pedersen JS, Bendtsen F, Møller S. Management of cirrhotic ascites. Ther
Adv Chronic Dis. 2015 May;6(3):124-37. doi: 10.1177/2040622315580069. PMID: 25954497; PMCID: PMC4416972.

161: Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES,
Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A,
Haflidadottir S, Bendtsen F. Liver Fibrosis, but No Other Histologic Features,
Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver
Disease. Gastroenterology. 2015 Aug;149(2):389-97.e10. doi:
10.1053/j.gastro.2015.04.043. Epub 2015 Apr 29. PMID: 25935633; PMCID:
PMC4516664.

162: Petersen AM, Halkjær SI, Gluud LL. Intestinal colonization with
phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a
systematic review and meta-analysis. Scand J Gastroenterol.
2015;50(10):1199-207. doi: 10.3109/00365521.2015.1028993. Epub 2015 Apr 24. PMID: 25910859.

163: Møller S, Bendtsen F. Complications of cirrhosis. A 50 years flashback.
Scand J Gastroenterol. 2015 Jun;50(6):763-80. doi:
10.3109/00365521.2015.1021709. Epub 2015 Apr 16. PMID: 25881709.

164: Junker AE, Gluud LL, Holst JJ, Knop FK, Vilsbøll T. Influence of
gastrointestinal factors on glucose metabolism in patients with cirrhosis. J
Gastroenterol Hepatol. 2015 Oct;30(10):1522-8. doi: 10.1111/jgh.12981. PMID:
25867498.

165: Ytting H, Larsen FS. Everolimus treatment for patients with autoimmune
hepatitis and poor response to standard therapy and drug alternatives in use.
Scand J Gastroenterol. 2015 Aug;50(8):1025-31. doi:
10.3109/00365521.2014.998271. Epub 2015 Apr 10. PMID: 25862144.

166: Risør LM, Bendtsen F, Møller S. Immunologic, hemodynamic, and adrenal
incompetence in cirrhosis: impact on renal dysfunction. Hepatol Int. 2015
Jan;9(1):17-27. doi: 10.1007/s12072-014-9581-1. Epub 2014 Sep 27. PMID:
25788375.

167: Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK,
Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy.
Cochrane Database Syst Rev. 2015 Feb 25;(2):CD001939. doi:
10.1002/14651858.CD001939.pub2. Update in: Cochrane Database Syst Rev.
2015;(9):CD001939. PMID: 25715177.

168: Fialla AD, Israelsen M, Hamberg O, Krag A, Gluud LL. Nutritional therapy in
cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis. Liver
Int. 2015 Sep;35(9):2072-8. doi: 10.1111/liv.12798. Epub 2015 Feb 15. PMID:
25645300.

169: Leeming DJ, Veidal SS, Karsdal MA, Nielsen MJ, Trebicka J, Busk T, Bendtsen
F, Krag A, Møller S. Pro-C5, a marker of true type V collagen formation and
fibrillation, correlates with portal hypertension in patients with alcoholic
cirrhosis. Scand J Gastroenterol. 2015 May;50(5):584-92. doi:
10.3109/00365521.2014.996590. Epub 2015 Feb 1. PMID: 25639675.

170: Junker AE, Gluud LL, Pedersen J, Langhoff JL, Holst JJ, Knop FK, Vilsbøll
T. A 25-year-old woman with type 2 diabetes and liver disease. Case Rep
Gastroenterol. 2014 Dec 12;8(3):398-403. doi: 10.1159/000369968. PMID: 25606030; PMCID: PMC4296242.

171: Thiele M, Albillos A, Abazi R, Wiest R, Gluud LL, Krag A. Non-selective
beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of
randomized trials. Liver Int. 2015 Aug;35(8):2009-16. doi: 10.1111/liv.12782.
Epub 2015 Feb 6. PMID: 25581713.

172: Krag A, Gluud LL. Reply. When to stop non-selective beta-blockers: the
window hypothesis in clinical practice. J Gastrointestin Liver Dis. 2014
Dec;23(4):458. PMID: 25532009.

173: Gluud LL, Knop FK, Vilsbøll T. Effects of lixisenatide on elevated liver
transaminases: systematic review with individual patient data meta-analysis of
randomised controlled trials on patients with type 2 diabetes. BMJ Open. 2014
Dec 19;4(12):e005325. doi: 10.1136/bmjopen-2014-005325. PMID: 25526792; PMCID: PMC4275683.

174: Bennett C, Klingenberg SL, Langholz E, Gluud LL. Tranexamic acid for upper
gastrointestinal bleeding. Cochrane Database Syst Rev. 2014 Nov
21;2014(11):CD006640. doi: 10.1002/14651858.CD006640.pub3. PMID: 25414987; PMCID: PMC6599825.

175: Henriksen UL, Hansen HB, Ring-Larsen H, Bendtsen F, Henriksen JH. Total
plasma clearance versus urinary plasma clearance of (51)Cr-EDTA in patients with
cirrhosis with and without fluid retention. Scand J Clin Lab Invest. 2015
Jan;75(1):64-72. doi: 10.3109/00365513.2014.980313. Epub 2014 Nov 20. PMID: 25410087.

176: Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis
and portal hypertension: haemodynamic and homeostatic aspects. World J
Gastroenterol. 2014 Nov 14;20(42):15499-517. doi: 10.3748/wjg.v20.i42.15499.
PMID: 25400435; PMCID: PMC4229516.

177: Mortensen C, Jensen JS, Hobolth L, Dam-Larsen S, Madsen BS, Andersen O,
Møller S, Bendtsen F. Association of markers of bacterial translocation with
immune activation in decompensated cirrhosis. Eur J Gastroenterol Hepatol. 2014
Dec;26(12):1360-6. doi: 10.1097/MEG.0000000000000217. PMID: 25357217.

178: Pind ML, Møller S, Faqir N, Bendtsen F. Predictive value of indocyanine
green retention test and indocyanine green clearance in Child-Pugh class A
patients. Hepatology. 2015 Jun;61(6):2112-3. doi: 10.1002/hep.27569. Epub 2015 Apr 23. PMID: 25330382.

179: Krag A, Bendtsen F, Dahl EK, Kjær A, Petersen CL, Møller S. Cardiac
function in patients with early cirrhosis during maximal beta-adrenergic drive:
a dobutamine stress study. PLoS One. 2014 Oct 3;9(10):e109179. doi:
10.1371/journal.pone.0109179. PMID: 25279659; PMCID: PMC4184863.

180: Jansen C, Leeming DJ, Mandorfer M, Byrjalsen I, Schierwagen R, Schwabl P,
Karsdal MA, Anadol E, Strassburg CP, Rockstroh J, Peck-Radosavljevic M, Møller
S, Bendtsen F, Krag A, Reiberger T, Trebicka J. PRO-C3-levels in patients with
HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.
PLoS One. 2014 Sep 29;9(9):e108544. doi: 10.1371/journal.pone.0108544. PMID: 25265505; PMCID: PMC4180447.

181: Storgaard H, Gluud LL, Christensen M, Knop FK, Vilsbøll T. The effects of
sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes:
protocol for a systematic review with meta-analysis of randomised trials. BMJ
Open. 2014;4(8):e005378. doi: 10.1136/bmjopen-2014-005378. PMID: 25232561; PMCID: PMC4139650.

182: Thiele M, Gluud LL, Fialla AD, Dahl EK, Krag A. Large variations in risk of
hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients:
systematic review with meta-analyses. PLoS One. 2014 Sep 16;9(9):e107177. doi:
10.1371/journal.pone.0107177. PMID: 25225801; PMCID: PMC4167336.

183: Kimer N, Krag A, Gluud LL. Letter: the effects of rifaximin in hepatic
encephalopathy--authors' reply. Aliment Pharmacol Ther. 2014 Oct;40(7):858-9.
doi: 10.1111/apt.12904. PMID: 25185737.

184: Egerod Israelsen M, Gluud LL, Krag A. Acute kidney injury and hepatorenal
syndrome in cirrhosis. J Gastroenterol Hepatol. 2015 Feb;30(2):236-43. doi:
10.1111/jgh.12709. PMID: 25160511.

185: Vester-Andersen MK, Vind I, Prosberg MV, Bengtsson BG, Blixt T, Munkholm P,
Andersson M, Jess T, Bendtsen F. Hospitalisation, surgical and medical
recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-
based cohort study. J Crohns Colitis. 2014 Dec;8(12):1675-83. doi:
10.1016/j.crohns.2014.07.010. Epub 2014 Aug 22. PMID: 25154681.

186: Leeming DJ, Anadol E, Schierwagen R, Karsdal MA, Byrjalsen I, Nielsen MJ,
Schwarzer-Zander C, Boesecke C, Bendtsen F, Møller S, Strassburg CP, Spengler U,
Krag A, Rockstroh J, Trebicka JK. Combined antiretroviral therapy attenuates
hepatic extracellular matrix remodeling in HIV patients assessed by novel
protein fingerprint markers. AIDS. 2014 Sep 10;28(14):2081-90. doi:
10.1097/QAD.0000000000000388. PMID: 25136933.

187: Kimer N, Feineis M, Møller S, Bendtsen F. Beta-blockers in cirrhosis and
refractory ascites: a retrospective cohort study and review of the literature.
Scand J Gastroenterol. 2015 Feb;50(2):129-37. doi: 10.3109/00365521.2014.948053. Epub 2014 Aug 12. PMID: 25113796.

188: Bendtsen F, Larsen FS, Ott P, Vilstrup H. [Cirrhosis of the liver]. Ugeskr
Laeger. 2014 Feb 17;176(4):V02130126. Danish. PMID: 25095867.

189: Busk TM, Bendtsen F, Nielsen HJ, Jensen V, Brünner N, Møller S. TIMP-1 in
patients with cirrhosis: relation to liver dysfunction, portal hypertension, and
hemodynamic changes. Scand J Gastroenterol. 2014 Sep;49(9):1103-10. doi:
10.3109/00365521.2014.934910. Epub 2014 Jul 22. PMID: 25048331.

190: Bang UC, Benfield T, Hyldstrup L, Bendtsen F, Beck Jensen JE. Reply: To
PMID 24389306. Gastroenterology. 2014 Aug;147(2):542. doi:
10.1053/j.gastro.2014.06.032. Epub 2014 Jun 25. PMID: 24973684.

191: Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Krstic G, Wetterslev J,
Gluud C. Vitamin D supplementation for prevention of cancer in adults. Cochrane
Database Syst Rev. 2014 Jun 23;(6):CD007469. doi: 10.1002/14651858.CD007469.pub2. PMID: 24953955.

192: Krag A, Gluud LL. Cross-talk between the liver, heart and kidney - another
piece in the puzzle. J Gastrointestin Liver Dis. 2014 Jun;23(2):119-21. doi:
10.15403/jgld.2014.1121.ak1. PMID: 24949601.

193: Trebicka J, Wix C, von Heydebrand M, Hittatiya K, Reiberger T, Klein S,
Schierwagen R, Kristiansen G, Peck-Radosavljevic M, Fischer HP, Møller S,
Bendtsen F, Krag A, Sauerbruch T. Expression of vasoactive proteins in gastric
antral mucosa reflects vascular dysfunction in patients with cirrhosis and
portal hypertension. Liver Int. 2015 Apr;35(4):1393-402. doi: 10.1111/liv.12613.
Epub 2014 Jul 5. PMID: 24912856.

194: Kimer N, Krag A, Møller S, Bendtsen F, Gluud LL. Systematic review with
meta-analysis: the effects of rifaximin in hepatic encephalopathy. Aliment
Pharmacol Ther. 2014 Jul;40(2):123-32. doi: 10.1111/apt.12803. Epub 2014 May 21. PMID: 24849268.

195: Bendtsen F, D'Amico G, Rusch E, de Franchis R, Andersen PK, Lebrec D,
Thabut D, Bosch J. Effect of recombinant Factor VIIa on outcome of acute
variceal bleeding: an individual patient based meta-analysis of two controlled
trials. J Hepatol. 2014 Aug;61(2):252-9. doi: 10.1016/j.jhep.2014.03.035. Epub
2014 Apr 5. PMID: 24713188.

196: Møller S, Krag A, Bendtsen F. Kidney injury in cirrhosis:
pathophysiological and therapeutic aspects of hepatorenal syndromes. Liver Int.
2014 Sep;34(8):1153-63. doi: 10.1111/liv.12549. Epub 2014 Apr 12. PMID:
24673771.

197: Kimer N, Krag A, Gluud LL. Safety, efficacy, and patient acceptability of
rifaximin for hepatic encephalopathy. Patient Prefer Adherence. 2014 Mar
18;8:331-8. doi: 10.2147/PPA.S41565. PMID: 24672227; PMCID: PMC3964161.

198: Vester-Andersen MK, Prosberg MV, Jess T, Andersson M, Bengtsson BG, Blixt
T, Munkholm P, Bendtsen F, Vind I. Disease course and surgery rates in
inflammatory bowel disease: a population-based, 7-year follow-up study in the
era of immunomodulating therapy. Am J Gastroenterol. 2014 May;109(5):705-14.
doi: 10.1038/ajg.2014.45. Epub 2014 Mar 18. PMID: 24642581.

199: Bendtsen F. Patienter med dekompenseret cirrose bør ved udskrivelse
tilbydes rehabilitering [Patients with decompensated cirrhosis should be offered
rehabilitation at discharge]. Ugeskr Laeger. 2013 Oct 28;175(44):2625. Danish.
PMID: 24629193.

200: Hauser G, Awad T, Brok J, Thorlund K, Štimac D, Mabrouk M, Gluud C, Gluud
LL. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic
hepatitis C. Cochrane Database Syst Rev. 2014 Feb 28;(2):CD005441. doi:
10.1002/14651858.CD005441.pub3. PMID: 24585509.

201: Junker AE, Als-Nielsen B, Gluud C, Gluud LL. Dopamine agents for hepatic
encephalopathy. Cochrane Database Syst Rev. 2014 Feb 10;(2):CD003047. doi:
10.1002/14651858.CD003047.pub3. PMID: 24515383.

202: Thiele M, Askgaard G, Timm HB, Hamberg O, Gluud LL. Predictors of health-
related quality of life in outpatients with cirrhosis: results from a
prospective cohort. Hepat Res Treat. 2013;2013:479639. doi: 10.1155/2013/479639. Epub 2013 Dec 22. PMID: 24490061; PMCID: PMC3896069.

203: Kimer N, Goetze JP, Bendtsen F, Møller S. New vasoactive peptides in
cirrhosis: organ extraction and relation to the vasodilatory state. Eur J Clin
Invest. 2014 May;44(5):441-52. doi: 10.1111/eci.12249. Epub 2014 Feb 26. PMID: 24476551.

204: Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti
RG, Bjelakovic M, Gluud C. Vitamin D supplementation for prevention of mortality
in adults. Cochrane Database Syst Rev. 2014 Jan 10;(1):CD007470. doi:
10.1002/14651858.CD007470.pub3. PMID: 24414552.

205: Bang UC, Benfield T, Hyldstrup L, Bendtsen F, Beck Jensen JE. Mortality,
cancer, and comorbidities associated with chronic pancreatitis: a Danish
nationwide matched-cohort study. Gastroenterology. 2014 Apr;146(4):989-94. doi:
10.1053/j.gastro.2013.12.033. Epub 2013 Dec 31. PMID: 24389306.

206: Trebicka J, Krag A, Gansweid S, Schiedermaier P, Strunk HM, Fimmers R,
Strassburg CP, Bendtsen F, Møller S, Sauerbruch T, Spengler U. Soluble TNF-
alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis
and portal hypertension. PLoS One. 2013 Dec 26;8(12):e83341. doi:
10.1371/journal.pone.0083341. PMID: 24386183; PMCID: PMC3873322.

207: Dahl EK, Møller S, Kjær A, Petersen CL, Bendtsen F, Krag A. Diastolic and
autonomic dysfunction in early cirrhosis: a dobutamine stress study. Scand J
Gastroenterol. 2014 Mar;49(3):362-72. doi: 10.3109/00365521.2013.867359. Epub 2013 Dec 16. PMID: 24329122.

208: Stokes CS, Gluud LL, Casper M, Lammert F. Ursodeoxycholic acid and diets
higher in fat prevent gallbladder stones during weight loss: a meta-analysis of
randomized controlled trials. Clin Gastroenterol Hepatol. 2014
Jul;12(7):1090-1100.e2; quiz e61. doi: 10.1016/j.cgh.2013.11.031. Epub 2013 Dec 7. PMID: 24321208.

209: Wiese S, Mortensen C, Gøtze JP, Christensen E, Andersen O, Bendtsen F,
Møller S. Cardiac and proinflammatory markers predict prognosis in cirrhosis.
Liver Int. 2014 Jul;34(6):e19-30. doi: 10.1111/liv.12428. Epub 2014 Jan 7. PMID:
24313898.

210: Hobolth L, Bendtsen F, Hansen EF, Møller S. Effects of carvedilol and
propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised
study. Dig Liver Dis. 2014 Mar;46(3):251-6. doi: 10.1016/j.dld.2013.10.013. Epub
2013 Nov 26. PMID: 24290869.

211: Wiese S, Hove JD, Bendtsen F, Møller S. Cirrhotic cardiomyopathy:
pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2014
Mar;11(3):177-86. doi: 10.1038/nrgastro.2013.210. Epub 2013 Nov 12. PMID:
24217347.

212: El-Hussuna A, Krag A, Olaison G, Bendtsen F, Gluud LL. The effect of anti-
tumor necrosis factor alpha agents on postoperative anastomotic complications in
Crohn's disease: a systematic review. Dis Colon Rectum. 2013 Dec;56(12):1423-33. doi: 10.1097/DCR.0b013e3182a48505. PMID: 24201398.

213: Foghsgaard S, Vedtofte L, Mathiesen ER, Svare JA, Gluud LL, Holst JJ, Damm
P, Knop FK, Vilsbøll T. The effect of a glucagon-like peptide-1 receptor agonist
on glucose tolerance in women with previous gestational diabetes mellitus:
protocol for an investigator-initiated, randomised, placebo-controlled, double-
blinded, parallel intervention trial. BMJ Open. 2013 Oct 30;3(10):e003834. doi:
10.1136/bmjopen-2013-003834. PMID: 24176797; PMCID: PMC3816238.

214: Krag A, Munkholm P, Israelsen H, von Ryberg B, Andersen KK, Bendtsen F.
Profermin is efficacious in patients with active ulcerative colitis--a
randomized controlled trial. Inflamm Bowel Dis. 2013 Nov;19(12):2584-92. doi:
10.1097/01.MIB.0000437046.26036.db. PMID: 24108114.

215: Leeming DJ, Karsdal MA, Byrjalsen I, Bendtsen F, Trebicka J, Nielsen MJ,
Christiansen C, Møller S, Krag A. Novel serological neo-epitope markers of
extracellular matrix proteins for the detection of portal hypertension. Aliment
Pharmacol Ther. 2013 Nov;38(9):1086-96. doi: 10.1111/apt.12484. Epub 2013 Sep 15. PMID: 24099470; PMCID: PMC3935409.

216: Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T, Knop
FK. Secretion of glucose-dependent insulinotropic polypeptide in patients with
type 2 diabetes: systematic review and meta-analysis of clinical studies.
Diabetes Care. 2013 Oct;36(10):3346-52. doi: 10.2337/dc13-0465. PMID: 24065842; PMCID: PMC3781498.

217: Thiele M, Wiest R, Gluud LL, Albillos A, Krag A. Can non-selective beta-
blockers prevent hepatocellular carcinoma in patients with cirrhosis? Med
Hypotheses. 2013 Nov;81(5):871-4. doi: 10.1016/j.mehy.2013.08.026. Epub 2013 Sep 4. PMID: 24060485.

218: Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK. Effect of the
EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for
systematic review and meta-analysis of clinical studies. BMJ Open. 2013 Sep
13;3(9):e003417. doi: 10.1136/bmjopen-2013-003417. PMID: 24038010; PMCID: PMC3773645.

219: Thiele M, Gluud LL, Dahl EK, Krag A. Antiviral therapy for prevention of
hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review
and meta-analysis. BMJ Open. 2013 Aug 14;3(8):e003265. doi: 10.1136/bmjopen-2013-003265. PMID: 23945731; PMCID: PMC3752055.

220: Thyssen JP, Vester L, Grønhøj Larsen C, Smidt K, Jakobsen P, Hansen SH,
Vind-Kezunovic D, Gluud LL, Grønhøj Larsen F. The single-dose pharmacokinetics
of alitretinoin and its metabolites are not significantly altered in patients
with cirrhosis. Br J Dermatol. 2014 Feb;170(2):408-14. doi: 10.1111/bjd.12546.
PMID: 23909409.

221: von Tetzchner S, Verdel M, Barstad BG, Gravås EM, Jahnsen R, Krabbe S,
Ramstad K, Schiørbeck H, Skjeldal OH, Tranheim RS, Bang B, Jensen B, Jensen H,
Kildemoes L, Mottlau J, Rasmussen KV, Ytting H. The effect of interventions
based on the programs of The Institutes for the Achievement of Human Potential
and Family Hope Center. Dev Neurorehabil. 2013 Aug;16(4):217-29. doi:
10.3109/17518423.2012.739211. PMID: 23834196.

222: Mortensen C, Karlsen S, Grønbæk H, Nielsen DT, Frevert S, Clemmesen JO,
Møller S, Jensen JS, Bendtsen F. No difference in portal and hepatic venous
bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic
portosystemic shunt insertion. Liver Int. 2013 Oct;33(9):1309-15. doi:
10.1111/liv.12205. Epub 2013 Jun 14. PMID: 23763259.

223: Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Risum
N, Vilstrup H. Oral branched-chain amino acids have a beneficial effect on
manifestations of hepatic encephalopathy in a systematic review with meta-
analyses of randomized controlled trials. J Nutr. 2013 Aug;143(8):1263-8. doi:
10.3945/jn.113.174375. Epub 2013 Jun 5. PMID: 23739310.

224: Egerod Israelsen M, Gluud LL, Bendtsen F, Møller S, Krag AA. Hepatorenalt
syndrom: diagnose, behandling og forebyggelse [Hepatorenal syndrome: diagnosis,
treatment and prevention]. Ugeskr Laeger. 2013 May 27;175(22):1562-6. Danish.
PMID: 23721840.

225: Bang UC, Benfield T, Bendtsen F, Hyldstrup L, Beck Jensen JE. The risk of
fractures among patients with cirrhosis or chronic pancreatitis. Clin
Gastroenterol Hepatol. 2014 Feb;12(2):320-6. doi: 10.1016/j.cgh.2013.04.031.
Epub 2013 May 2. PMID: 23644391.

226: Henriksen UL, Henriksen JH, Bendtsen F, Møller S. (99m) Tc-labelled human
serum albumin cannot replace (125) I-labelled human serum albumin to determine
plasma volume in patients with liver disease. Clin Physiol Funct Imaging. 2013
May;33(3):211-7. doi: 10.1111/cpf.12015. Epub 2012 Dec 26. PMID: 23522015.

227: Jeppesen JB, Mortensen C, Bendtsen F, Møller S. Lactate metabolism in
chronic liver disease. Scand J Clin Lab Invest. 2013;73(4):293-9. doi:
10.3109/00365513.2013.773591. Epub 2013 Mar 20. PMID: 23514017.

228: Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T, Knop
FK. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes
mellitus: systematic review and meta-analyses of clinical studies. Diabetologia.
2013 May;56(5):965-72. doi: 10.1007/s00125-013-2841-0. Epub 2013 Feb 3. PMID: 23377698; PMCID: PMC3687347.

229: Busk TM, Bendtsen F, Møller S. Cardiac and renal effects of a transjugular
intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol. 2013
May;25(5):523-30. doi: 10.1097/MEG.0b013e32835d09fe. PMID: 23325273.

230: Lauridsen MM, Thiele M, Kimer N, Vilstrup H. The continuous reaction times
method for diagnosing, grading, and monitoring minimal/covert hepatic
encephalopathy. Metab Brain Dis. 2013 Jun;28(2):231-4. doi:
10.1007/s11011-012-9373-z. Epub 2013 Jan 10. PMID: 23299303.

231: Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK,
Vilstrup H. Lactulose, rifaximin or branched chain amino acids for hepatic
encephalopathy: what is the evidence? Metab Brain Dis. 2013 Jun;28(2):221-5.
doi: 10.1007/s11011-012-9372-0. Epub 2012 Dec 29. PMID: 23275147.

232: Ytting H, Larsen FS. Karakteristik, diagnostik og behandling af patienter
med autoimmun hepatitis [Characteristics, diagnosis and therapy of patients with
autoimmune hepatitis]. Ugeskr Laeger. 2012 Nov 12;174(46):2859-63. Danish. PMID: 23153467.

233: Hansen M, Sonne DP, Mikkelsen KH, Gluud LL, Vilsbøll T, Knop FK. Effect of
bile acid sequestrants on glycaemic control: protocol for a systematic review
with meta-analysis of randomised controlled trials. BMJ Open. 2012 Nov
12;2(6):e001803. doi: 10.1136/bmjopen-2012-001803. PMID: 23148345; PMCID: PMC3533035.

234: Kimer N, Dahl EK, Gluud LL, Krag A. Antiviral therapy for prevention of
hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-
analysis of randomised controlled trials. BMJ Open. 2012 Oct 22;2(5):e001313.
doi: 10.1136/bmjopen-2012-001313. PMID: 23089208; PMCID: PMC4400677.

235: Møller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic
cardiomyopathy. Int J Cardiol. 2013 Aug 20;167(4):1101-8. doi:
10.1016/j.ijcard.2012.09.089. Epub 2012 Oct 4. PMID: 23041091.

236: Bonefeld K, Hobolth L, Juul A, Møller S. The insulin like growth factor
system in cirrhosis. Relation to changes in body composition following
adrenoreceptor blockade. Growth Horm IGF Res. 2012 Dec;22(6):212-8. doi:
10.1016/j.ghir.2012.09.001. Epub 2012 Sep 30. PMID: 23031335.

237: Møller S, Mortensen C, Bendtsen F, Jensen LT, Gøtze JP, Madsen JL. Cardiac
sympathetic imaging with mIBG in cirrhosis and portal hypertension: relation to
autonomic and cardiac function. Am J Physiol Gastrointest Liver Physiol. 2012
Dec 1;303(11):G1228-35. doi: 10.1152/ajpgi.00303.2012. Epub 2012 Sep 27. PMID: 23019196.

238: Savović J, Jones H, Altman D, Harris R, Jűni P, Pildal J, Als-Nielsen B,
Balk E, Gluud C, Gluud L, Ioannidis J, Schulz K, Beynon R, Welton N, Wood L,
Moher D, Deeks J, Sterne J. Influence of reported study design characteristics
on intervention effect estimates from randomised controlled trials: combined
analysis of meta-epidemiological studies. Health Technol Assess. 2012
Sep;16(35):1-82. doi: 10.3310/hta16350. PMID: 22989478.

239: Gluud LL, Christensen K, Christensen E, Krag A. Terlipressin for
hepatorenal syndrome. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD005162. doi: 10.1002/14651858.CD005162.pub3. Update in: Cochrane Database Syst Rev. 2017 Jun 14;6:CD005162. PMID: 22972083.

240: Pedersen N, Elkjaer M, Duricova D, Burisch J, Dobrzanski C, Andersen NN,
Jess T, Bendtsen F, Langholz E, Leotta S, Knudsen T, Thorsgaard N, Munkholm P.
eHealth: individualisation of infliximab treatment and disease course via a
self-managed web-based solution in Crohn’s disease. Aliment Pharmacol Ther. 2012 Nov;36(9):840-9. doi: 10.1111/apt.12043. PMID: 22971016.

241: Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B,
Balk EM, Gluud C, Gluud LL, Ioannidis JP, Schulz KF, Beynon R, Welton NJ, Wood
L, Moher D, Deeks JJ, Sterne JA. Influence of reported study design
characteristics on intervention effect estimates from randomized, controlled
trials. Ann Intern Med. 2012 Sep 18;157(6):429-38. doi: 10.7326/0003-4819-157-6-201209180-00537. PMID: 22945832.

242: Dahl E, Gluud LL, Kimer N, Krag A. Meta-analysis: the safety and efficacy
of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or
hyponatraemia. Aliment Pharmacol Ther. 2012 Oct;36(7):619-26. doi:
10.1111/apt.12025. Epub 2012 Aug 21. PMID: 22908905.

243: Gluud LL, Krag A. Banding ligation versus beta-blockers for primary
prevention in oesophageal varices in adults. Cochrane Database Syst Rev. 2012
Aug 15;(8):CD004544. doi: 10.1002/14651858.CD004544.pub2. PMID: 22895942.

244: Hobolth L, Bendtsen F, Møller S. Indications for portal pressure
measurement in chronic liver disease. Scand J Gastroenterol. 2012
Sep;47(8-9):887-92. doi: 10.3109/00365521.2012.706827. Epub 2012 Jul 19. PMID: 22809270.

245: Nielsen BR, Schwarz P, Friis S, Gluud LL. Elevated liver enzymes, anaemia
and osteopaenia in a young woman. BMJ Case Rep. 2012 Jun 15;2012:bcr0320126112. doi: 10.1136/bcr-03-2012-6112. PMID: 22717932; PMCID: PMC4542672.

246: Krag A, Israelsen H, von Ryberg B, Andersen KK, Bendtsen F. Safety and
efficacy of Profermin® to induce remission in ulcerative colitis. World J
Gastroenterol. 2012 Apr 21;18(15):1773-80. doi: 10.3748/wjg.v18.i15.1773. PMID: 22553401; PMCID: PMC3332290.

247: Holte K, Krag A, Gluud LL. Systematic review and meta-analysis of
randomized trials on probiotics for hepatic encephalopathy. Hepatol Res. 2012
Oct;42(10):1008-15. doi: 10.1111/j.1872-034X.2012.01015.x. Epub 2012 Apr 30. PMID: 22548675.

248: Krag A, Bendtsen F, Burroughs AK, Møller S. The cardiorenal link in
advanced cirrhosis. Med Hypotheses. 2012 Jul;79(1):53-5. doi:
10.1016/j.mehy.2012.03.032. Epub 2012 Apr 24. PMID: 22537409.

249: Thiele M, Krag A, Rohde U, Gluud LL. Meta-analysis: banding ligation and
medical interventions for the prevention of rebleeding from oesophageal varices.
Aliment Pharmacol Ther. 2012 May;35(10):1155-65. doi:
10.1111/j.1365-2036.2012.05074.x. Epub 2012 Mar 26. PMID: 22449261.

250: Mortensen C, Andersen O, Krag A, Bendtsen F, Møller S. High-sensitivity
C-reactive protein levels predict survival and are related to haemodynamics in
alcoholic cirrhosis. Eur J Gastroenterol Hepatol. 2012 Jun;24(6):619-26. doi:
10.1097/MEG.0b013e328351db6e. PMID: 22441510.

251: Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant
supplements for prevention of mortality in healthy participants and patients
with various diseases. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD007176.
doi: 10.1002/14651858.CD007176.pub2. PMID: 22419320.

252: Henriksen JH, Fuglsang S, Bendtsen F. Arterial pressure profile in patients
with cirrhosis: Fourier analysis of arterial pulse in relation to pressure
level, stroke volume, and severity of disease: on the reduction of afterload in
the hyperdynamic syndrome. Scand J Gastroenterol. 2012 May;47(5):580-90. doi:
10.3109/00365521.2012.658856. Epub 2012 Mar 14. PMID: 22414026.

253: Bregnbak D, Mortensen C, Bendtsen F. Infliximab and complications after
colectomy in patients with ulcerative colitis. J Crohns Colitis. 2012
Apr;6(3):281-6. doi: 10.1016/j.crohns.2011.08.014. Epub 2011 Sep 25. PMID:
22405163.

254: Hobolth L, Møller S, Grønbæk H, Roelsgaard K, Bendtsen F, Feldager Hansen
E. Carvedilol or propranolol in portal hypertension? A randomized comparison.
Scand J Gastroenterol. 2012 Apr;47(4):467-74. doi: 10.3109/00365521.2012.666673. Epub 2012 Mar 9. PMID: 22401315.

255: Theocharidou E, Krag A, Bendtsen F, Møller S, Burroughs AK. Cardiac
dysfunction in cirrhosis - does adrenal function play a role? A hypothesis.
Liver Int. 2012 Oct;32(9):1327-32. doi: 10.1111/j.1478-3231.2011.02751.x. Epub 2012 Jan 31. PMID: 22292920.

256: Gluud LL, Klingenberg SL, Langholz E. Tranexamic acid for upper
gastrointestinal bleeding. Cochrane Database Syst Rev. 2012 Jan 18;1:CD006640.
doi: 10.1002/14651858.CD006640.pub2. Update in: Cochrane Database Syst Rev. 2014;11:CD006640. PMID: 22258969.

257: Møller S, Aagaard NK, Schmidt L, Grønbaek H, Hansen JB, Bendtsen F.
Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Dan Med J. 2012 Jan;59(1):C4372. PMID: 22239848.

258: Bendtsen F, Grønbaek H, Hansen JB, Aagaard NK, Schmidt L, Møller S.
Treatment of ascites and spontaneous bacterial peritonitis - part I. Dan Med J.
2012 Jan;59(1):C4371. PMID: 22239847.

259: Semb S, Dam-Larsen S, Mogensen AM, Albrectsen J, Bendtsen F. Low incidence of non-alcoholic steatohepatitis in a Danish liver unit. Dan Med J. 2012
Jan;59(1):A4354. PMID: 22239839.

260: Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of
glucagon-like peptide-1 receptor agonists on weight loss: systematic review and
meta-analyses of randomised controlled trials. BMJ. 2012 Jan 10;344:d7771. doi:
10.1136/bmj.d7771. PMID: 22236411; PMCID: PMC3256253.

261: Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic
and non-haemodynamic effects of β-blockers improve survival of patients with
cirrhosis during a window in the disease. Gut. 2012 Jul;61(7):967-9. doi:
10.1136/gutjnl-2011-301348. Epub 2012 Jan 10. PMID: 22234982.

262: Buchard A, Eefsen M, Semb S, Andersen SE, Morling N, Bendtsen F, Larsen FS, Dalhoff K. The role of the glutathione S-transferase genes GSTT1, GSTM1, and
GSTP1 in acetaminophen-poisoned patients. Clin Toxicol (Phila). 2012 Jan;50(1):27-33. doi: 10.3109/15563650.2011.639713. Epub 2011 Dec 19. PMID: 22175791.

263: Krag A, Møller S, Burroughs AK, Bendtsen F. Betablockers induce cardiac
chronotropic incompetence. J Hepatol. 2012 Jan;56(1):298-9. doi:
10.1016/j.jhep.2011.04.033. PMID: 22173037.

264: Henriksen JH, Fuglsang S, Bendtsen F. Fourier analysis of arterial pulse in
patients with advanced cirrhosis indicates reduced wave reflections that may
protect against manifest cardiac dysfunction. Gut. 2012 Aug;61(8):1239-40. doi:
10.1136/gutjnl-2011-301598. Epub 2011 Dec 3. PMID: 22138534.

265: Nøjgaard C, Becker U, Matzen P, Andersen JR, Holst C, Bendtsen F.
Progression from acute to chronic pancreatitis: prognostic factors, mortality,
and natural course. Pancreas. 2011 Nov;40(8):1195-200. doi: 10.1097/MPA.0b013e318221f569. PMID: 21926938.

266: Afzelius P, Bazeghi N, Bie P, Bendtsen F, Vestbo J, Møller S. Circulating
nitric oxide products do not solely reflect nitric oxide release in cirrhosis
and portal hypertension. Liver Int. 2011 Oct;31(9):1381-7. doi:
10.1111/j.1478-3231.2011.02576.x. Epub 2011 Jul 5. PMID: 21745317.

267: Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti
RG, Bjelakovic M, Gluud C. Vitamin D supplementation for prevention of mortality
in adults. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007470. doi:
10.1002/14651858.CD007470.pub2. Update in: Cochrane Database Syst Rev.
2014;1:CD007470. PMID: 21735411.

268: Dahl E, Rumessen J, Gluud LL. Systematic review with meta-analyses of
studies on the association between cirrhosis and liver metastases. Hepatol Res.
2011 Jul;41(7):618-25. doi: 10.1111/j.1872-034X.2011.00813.x. PMID: 21711420.

269: Møller S, Hobolth L, Winkler C, Bendtsen F, Christensen E. Determinants of
the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut. 2011
Sep;60(9):1254-9. doi: 10.1136/gut.2010.235473. Epub 2011 Apr 19. PMID:
21504996.

270: Klingenberg SL, Nikolova D, Alexakis N, Als-Nielsen B, Colli A, Conte D,
D'Amico G, Davidson B, Fingerhut A, Fraquelli M, Gluud LL, Gurusamy K, Keus F,
Khan S, Koretz R, van Laarhoven C, Liu J, Myers R, Pagliaro L, Simonetti R,
Sutton R, Thorlund K, Gluud C. Hepato-biliary clinical trials and their
inclusion in the Cochrane Hepato-Biliary Group register and reviews. J
Gastroenterol Hepatol. 2011 Apr;26(4):649-56. doi: 10.1111/j.1440-1746.2010.06465.x. PMID: 21418299.

271: Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C.
Antioxidant supplements for liver diseases. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007749. doi: 10.1002/14651858.CD007749.pub2. PMID: 21412909.

272: Winkler C, Hobolth L, Krag A, Bendtsen F, Møller S. Effects of treatment
with β-blocker and aldosterone antagonist on central and peripheral
haemodynamics and oxygenation in cirrhosis. Eur J Gastroenterol Hepatol. 2011
Apr;23(4):334-42. doi: 10.1097/MEG.0b013e3283455b7f. PMID: 21399508.

273: Savović J, Harris RJ, Wood L, Beynon R, Altman D, Als-Nielsen B, Balk EM,
Deeks J, Gluud LL, Gluud C, Loannidis JP, Jűni P, Moher D, Pildal J, Schulz KF,
Sterne JA. Development of a combined database for meta-epidemiological research. Res Synth Methods. 2011 Mar;2(1):78. doi: 10.1002/jrsm.33. Epub 2011 Jun 10. Erratum for: Res Synth Methods. 2010 Jul;1(3-4):212-25. PMID: 26063638.

274: Mortensen C, Caspersen S, Christensen NL, Svenningsen L, Thorsgaard N,
Christensen LA, Bendtsen F. Treatment of acute ulcerative colitis with
infliximab, a retrospective study from three Danish hospitals. J Crohns Colitis.
2011 Feb;5(1):28-33. doi: 10.1016/j.crohns.2010.09.004. Epub 2010 Oct 13. PMID: 21272801.

275: Ytting H, Christensen IJ, Steffensen R, Alsner J, Thiel S, Jensenius JC,
Hansen U, Nielsen HJ. Mannan-binding lectin (MBL) and MBL-associated serine
protease 2 (MASP-2) genotypes in colorectal cancer. Scand J Immunol. 2011
Feb;73(2):122-7. doi: 10.1111/j.1365-3083.2010.02480.x. PMID: 21198752.

276: Nøjgaard C, Matzen P, Bendtsen F, Andersen JR, Christensen E, Becker U.
Factors associated with long-term mortality in acute pancreatitis. Scand J
Gastroenterol. 2011 Apr;46(4):495-502. doi: 10.3109/00365521.2010.537686. Epub 2010 Nov 22. PMID: 21091094.

277: Krag A, Pedersen EB, Møller S, Bendtsen F. Effects of the vasopressin
agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients
with cirrhosis and water retention. Scand J Clin Lab Invest. 2011
Apr;71(2):112-6. doi: 10.3109/00365513.2010.537369. Epub 2010 Nov 16. PMID: 21080762.



Redaktør